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ABSTRACT
Among bony vertebrates, the melanocortin-2 receptor ortholog is unique among the
family of five melanocortin receptors on the basis that it is dependent on its accessory
protein, MRAP1, for trafficking and activation, and is selective for activation by ACTH
alone. Previous studies on the MC2R orthologs of select cartilaginous fish, the elephant
shark (Callorhinchus milii) and the red stingray (Dasyatis akajei), revealed divergent traits
in a less obligatory relationship on MRAP1 and its ability to be activated by ACTH or the
MSH-sized peptides. However, observed traits were not consistent between these two
cartilaginous fish species, posing the question as to whether there is another divergence of
traits between subclasses of cartilaginous fish.

Nascent availability of another

cartilaginous fish genome, that of the whale shark (Rhincodon typus), provided the
opportunity for classification of another cartilaginous fish MC2R ortholog. This new
information allowed for the possibility of more thoroughly determining the phylogeny of
MC2R traits in vertebrates. Initial characterization of the wsMC2R ortholog showed that
it was able to be activated by either ACTH or the MSH-sized peptides. While this ortholog
did not show a full dependence on MRAP1 for basal function, co-expression of wsMRAP1
or wsMRAP2 improved function overall. Analysis of the activation mechanism of the
wsMC2R ortholog suggested a hybrid mechanism between the proposed one-step
activation mechanism for the elephant shark MC2R ortholog and the proposed two-step
activation mechanism for the bony vertebrate MC2R orthologs. In addition to analysis of
ii

the activation of wsMC2R, attention was focused to the relationship of the wsMC2R
ortholog and wsMC2R, specifically to the region of their interaction. Analysis of the
extracellular regions of wsMC2R utilizing a chimeric receptor approach revealed that it is
unlikely the N-terminal of wsMRAP1 is interacting with an extracellular region of
wsMC2R. A similar chimeric receptor approach extended to the TM4 and TM5 regions of
the wsMC2R ortholog revealed that the likely region of interaction between wsMC2R and
wsMRAP1 to facilitate trafficking of the receptor to the plasma membrane is specific to
residues within TM5. The present thesis contributes to the body of knowledge which
develops a picture of the phylogenetic relationship between MC2R orthologs and MRAP
orthologs of extant vertebrates.
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CHAPTER ONE: AN INTRODUCTION TO THE MELANOCORTIN-2 RECEPTOR

The Melanocortin Receptors
The family of melanocortin receptors (MCRs) includes five G-protein-coupled
receptors (GPCRs) in the rhodopsin type-A subclass (Cone 2006). GPCRs are classified
by the structure of a single-chain seven transmembrane protein and their functional
coupling to various G-proteins for physiological functioning (Devi 2005). Among the
GPCRs, the MCRs are considered to be some of the smallest, having no introns and very
small N- and C-termini (Horn et al. 2003). This family of receptors is thought to have
emerged as a result of two whole genome duplication events and one local gene duplication
event (Schioth et al. 2005, Dores et al. 2013).
The MCRs are hormone-activated receptors which are expressed differentially in
tissues throughout the body, each having a distinctive role in physiological functioning
(Cone 2006). The melanocortin-1 receptor (MC1R) is mainly expressed in melanocytes
and is most commonly associated with pigmentation in vertebrates, but is also expressed
in certain areas of the brain and macrophages (Chhajlani and Wikberg 1992, GarciaBorron et al. 2005). Melanocortin receptors 3 (MC3R) and 4 (MC4R) are largely expressed
in tissues of the central nervous system, playing an important part in energy homeostasis.
MC3R is also expressed in the placenta, stomach, and pancreas, contributing to its role in
1

metabolism (Gantz et al. 1993, Mountjoy and Wild 1998, Butler 2006). The melanocortin5 receptor is expressed most broadly in vertebrates, being found in gonadal, exocrine and
adrenal tissues although its main associated function is considered to be a role in exocrine
secretion (Chen et al. 1997, Cooray and Clark 2011). Finally, the melanocortin-2 receptor
(MC2R) is expressed on the adrenal cortex in cells of the zona fasciculata and is important
for steroidogenesis in the stress response axis (Chan et al. 2011).

The Melanocortin Peptides
All five MCRs are activated by melanocortin peptides which include
adrenocorticotropic hormone (ACTH) and melanocyte-stimulating hormone (MSH) which
are derivatives of the prohormone precursor protein proopiomelanocortin (POMC)
(Nakanishi et al. 1979, Dores and Baron 2011). The POMC gene is a member of the
opioid/orphanin gene family which contains four genes in vertebrates: POMC,
proenkephalain, proorphanin and prodynorphin (Dores et al. 2002). These four genes are
considered to have emerged after the 2R genome duplication event (Ohno et al. 1968,
Holland et al. 1992). All gnathostome POMC genes which have been studied reveal the
same organizational plan (Figure 1A), with ACTH positioned in the middle which contains

2

A

B

ACTH(1-24)
𝛂-MSH

SYSMEHFRWGKPVGKKRRPVKVYP
SYSMEHFRWGKPV

Figure 1. The Melanocortin peptides. A) Layout of POMC gene. The
overall structure of the POMC gene is highly conserved, with only minor
differences in peptide length noticed in various vertebrate species. The regions
which correspond to the most physiologically relevant peptide derivatives are
highly conserved, emphasizing the lasting biological importance and relevance
of this prohormone precursor (Harno et al. 2018). B) Sequence alignment of
human ACTH and human α-MSH. ACTH is released from the POMC
precursor through proteolytic cleavage by prohormone convertase 1 (PC1). A
second cleavage of this peptide product by prohormone convertase 2 (PC2)
produces α-MSH (Cerda-Reverter et al 2010).
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the sequence for α-MSH, and β-MSH and β-endorphin located near the C-terminal
(Vallarino et al. 2012). In cartilaginous fish and tetrapod POMC there is an additional γMSH, and cartilaginous fish alone have an additional δ-MSH sequence as well (Takahashi
et al. 2001, Dores and Baron 2011); whereas, the γ-MSH sequence is lacking in all teleosts
(i.e. modern bony fishes) (Dores and Lecaude 2005).
The melanocortin core peptide sequence, HFRW, which is necessary for activation
of all MCRs (Cone 2006) can be found in the overlapping sequence of ACTH and α-MSH
(Figure 1B). Within ACTH, the first 24 residues are 88% conserved in vertebrates, and
this region has been shown to have equivalent efficacy in activation of the MCRs as the
full peptide (Schwyzer 1977). The cleavage of POMC to separate ACTH and MSH to be
utilized in different physiological circuits is accomplished by distinct prohormone
convertases differentially expressed in the anterior and intermediate pituitary (Seidah and
Chreitien 1999, Cerda-Reverter et al. 2011). This organization becomes important in
regulation of the different MCRs. While MCRs 1, 3, 4, and 5 can all be activated by any
of the melanocortin peptides (α-MSH, β-MSH, γ-MSH, δ-MSH, ACTH), the MC2R
orthologs of bony vertebrates are selective for activation by ACTH alone (Cone 2006,
Dores and Garcia 2015).

The Melanocortin-2 Receptor
In addition to the unique ligand selective properties of bony vertebrate MC2R
orthologs, this receptor is dependent on the melanocortin receptor accessory protein 1
(MRAP1) for trafficking and activation (Metherell et al. 2005, Sebag and Hinkle 2009).
4

The obligatory relationship on MRAP1 was discovered when MC2R was only able to be
functionally expressed in adrenal-derived mammalian cell lines, not in non-adrenal cell
lines (Rached et al. 2005, Forti et al. 2006). Additionally, mutations in MRAP can also
cause corticosteroid insufficiency as FGD type II (FGD II; Webb and Clark 2010)
MRAP is a single-pass transmembrane protein which takes on reverse topology to
form a unique anti-parallel homodimer (Sebag and Hinkle 2007). There are two paralogs
of MRAP: MRAP1 and MRAP2 (Chan et al 2009, Sebag and Hinkle 2009, Webb and Clark
2010). Both paralogs have a membrane-spanning domain where they interact with the
MC2R, and a reverse topology motif (Figure 2A). However, MRAP1 (Figure 2B) is
distinct from MRAP2 (Figure 2C) because of a key, four-residue motif at the N-terminal
that is absolutely necessary for activation of MC2R, which MRAP2 lacks (Sebag and
Hinkle 2009). Alanine-substitution of this motif within MRAP1 prevents activation of
MC2R despite its presence at the cell surface (Sebag and Hinkle 2009). Since MRAP2
lacks this activation motif, it is able to assist trafficking of MC2R to the plasma membrane
but is unable to promote activation of MC2R (Sebag and Hinkle 2007).

5
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Figure 2. Sequence and motifs within human MRAP1. A) MC2R with
antiparallel homodimer of MRAP1. B) Peptide sequence of hMRAP1 with
denotation of key motifs: activation motif (yellow), reverse topology motif
(green), transmembrane domain (gray). C) Peptide sequence of hMRAP2 with
denotation of key motifs: reverse topology motif (green), transmembrane
domain (gray).
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The Hypothalamic-Pituitary-Adrenal Axis: MC2R in the Stress Response Cycle
MC2R is a necessary component for proper functioning of the stress response axis
(Figure 3). For humans, interruption of MC2R functioning due to genetic mutation results
in Familial Glucocorticoid Deficiency (FGD) which leads to symptoms ranging from
hyperpigmentation, hypoglycemia, and frequent infection, to failure to thrive causing
fatality in infancy (Clark and Weber 1998, Chan et al. 2008).
In normal functioning, the stress response cycle begins when an organism is
presented with any stimulus which is considered a threat to homeostasis (Selye 1976). The
first processing of the ‘stressor’ begins in the pontine and medullary neuronal systems
which ultimately project to the adrenal medulla, leading to the synthesis and release of
catecholamines into the systemic circulation (Hale 2015). At the same time, stimulus from
the splanchnic nerve contributes to both this release and increases the sensitivity of MC2R,
located on the adrenal cortex (Gjerstad 2018). The catecholamines bind the α-adrenergic
receptor on CRH-producing cells in the paraventricular nucleus (PVN) which then
effectively “turn-on” the hypothalamic-pituitary-adrenal (HPA) axis, depicted in Figure 1
(Tasker 2015). This activation of the HPA at the PVN leads to release of corticotropinreleasing hormone (CRH) into the median eminence which then travels to the anterior
pituitary via the hypophysial portal system (Vedder 2007). CRH binds to receptors on
pituitary corticotropes which stimulates synthesis and release of adrenocorticotropic
hormone (ACTH) into the systemic circulation, which then binds to the melanocortin-2
receptor on the cells of the zona fasciculata of the adrenal cortex to stimulate the synthesis
and release of cortisol (Bentley 1998).
7

Figure 3. The Hypothalamic-Pituitary-Adrenal (HPA) axis. When this
circuit is effectively “turned on” through stimulation by catecholamines, the
CRH-producing neurons in the hypothalamus release CRH into the median
eminence which activates ACTH-producing neurons in the pituitary. ACTH is
released into the systemic circulatory system where it travels to the adrenal
cortex, subsequently leading to the production of cortisol.
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The release of cortisol ‘completes’ the stress response cycle by incurring various
effects on the digestive system, adipose cells, liver and muscles in order to assist the body
in retuning to homeostasis (Romero and Butler 2007). Additionally, cortisol serves as the
negative feedback for glucocorticoid receptors (GR) which are expressed on the upstream
regulatory systems such as the hippocampus and amygdala (Tasker 2015).

Phylogeny of MC2R Orthologs
The salient traits of ligand selectivity for ACTH alone and dependence on MRAP1
have been consistently observed for all bony vertebrate MC2R orthologs studied (Figure
4; Cone 2006, Aguillero et al. 2010, Dores and Garcia 2015). It was thus assumed that
these traits were shared by all vertebrate MC2R orthologs. However, when the MC2R
ortholog of a cartilaginous fish, the elephant shark (es; Callorhincus millii), was analyzed,
it was discovered that this MC2R ortholog (esMC2R) did not have an obligatory
dependence on MRAP1 for trafficking and activation and was also able to be stimulated
by either ACTH or the MSH-sized ligands (Reinick et al. 2012). The sensitivity to
stimulation by ACTH of the esMC2R ortholog is increased only 10-fold when coexpressed with esMRAP1, and esMRAP1 had no positive or negative effect on trafficking
(Barney et al. 2019). Co-expression with the esMRAP2 ortholog also has no significant
effect on either activation or trafficking (Barney et al. 2019). In addition, analysis of
another cartilaginous fish MC2R ortholog (red stingray; sr; Dasyatis akajei) indicated that
this MC2R ortholog did not require co-expression with a cartilaginous fish MRAP1
ortholog for stimulation by either ACTH or the MSH-sized ligands, but stimulation was
9

limited to non-physiological concentrations of the ligands (i.e. 1 x 10-7/10-6 M; Takahashi
et al. 2016). However, activation of the srMC2R ortholog was increased 10,000-fold when
co-expressed with esMRAP1 (Dores et al. 2018) . There is no significant effect on srMC2R
activation or trafficking when co-expressed with esMRAP2. These observations revealed
two distinct mechanisms for the activation of MC2R in cartilaginous fishes, and both
mechanisms have features distinct from the mechanism of action of MC2R orthologs in
bony vertebrates as summarized in Figure 4.

For bony vertebrates there is a total

dependence on co-expression of MC2R with MRAP1 for trafficking and activation. In the
absence of MRAP1, MC2R will misfold at the endoplasmic reticulum which ultimately
leads to receptor degradation (Sebag and Hinkle 2009). However, for the esMC2R
ortholog, MRAP1 enhances stimulation of the receptor by ACTH, and for the srMC2R
ortholog, MRAP1 appears to facilitate “recovery” of activation of the receptor (Dores et
al. 2018, Barney et al. 2019).
The other main defining feature of bony vertebrate MC2R orthologs beside their
relationship with MRAP1 is the unique ligand selectivity for ACTH alone.

The

observation of ligand selectivity for ACTH alone for bony vertebrate MC2R orthologs has
been further analyzed in order to develop a thorough understanding of the activation
mechanism for ACTH with bony MC2R. These investigations are largely based on the
observation of the structure of ACTH itself, most importantly considering the motifs
H6F7R8W9 and K15K16R17R18. Characterizations utilizing alanine-substituted analogs of
hACTH(1-24) have been used to study the activation mechanisms for mammal (Liang et
al. 2013), avian (Barlock et al. 2014), amphibian (Davis et al. 2013), reptile (Davis et al.
10

Figure 4. Phylogeny of vertebrate MC2R traits. Within the phylogeny of
extant vertebrates, there is a key divergence in traits for MC2R orthologs
between the cartilaginous fishes and the bony vertebrates. Cartilaginous fish
MC2R orthologs are not dependent on MRAP1 for activation/trafficking, and
they are able to be activated by ACTH or the MSH-sized peptides. This is
contrary to what has been observed for the bony vertebrate MC2R orthologs,
which are dependent on MRAP1 for activation/trafficking and are selective for
stimulation by ACTH alone.
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2013) and teleost (Liang et al. 2015) MC2R orthologs. These studies revealed another
consistent pattern for bony vertebrate MC2R orthologs in that both the K15K16R17R18 and
H6F7R8W9 motifs are required for activation.
This realization led to the proposal of a two-step activation mechanism for bony
vertebrate MC2R which involves an initial binding of the K15K16R17R18 (tetrabasic) motif,
which leads to a conformation change in the receptor, allowing for accommodation of the
H6F7R8W9 motif and subsequent receptor activation (Davis et al. 2013, Liang et al. 2013,
Dores 2018). This model suggests that in the ‘off’ conformation, the binding site for
H6F7R8W9 is inaccessible to the ligand, and this motif is opened after interaction with the
K15K16R17R18 motif. This also provides an explanation for the inability of MSH-sized
ligands to activate bony vertebrate MC2R orthologs since these ligands lack the
K15K16R17R18 motif (Buckley and Ramachandran 1981, Mountjoy et al. 1994, Schwyzer
1977). Within this context, the activation mechanism of cartilaginous fish MC2R orthologs
comes into question on the basis that these orthologs can be activated by MSH-sized
ligands, apparently not requiring the K15K16R17R18 motif for activation. This suggested an
investigation into whether the cartilaginous fish MC2R orthologs also adopted a two-step
mechanism or if there is another mechanism at play.

Present Thesis Objectives: Part One
Based on the preceding comments it is clear that there is a dichotomy in the ligand
selective properties of gnathostome MC2R orthologs. For the bony vertebrates (i.e. bony
fishes, amphibians, reptiles, birds, and mammals), MC2R can only be activated by ACTH
12

and cannot be activated by any of the MSH-sized ligands (Mountjoy et al. 1992, Dores and
Garcia 2016). In addition to the ligand-selective properties of bony vertebrate MC2R, these
orthologs are dependent on co-expression with the accessory protein MRAP1 (Hinkle and
Sebag 2009, Webb and Clark 2010). However, based on studies for the MC2R orthologs
of the elephant shark and red stingray, it appears that cartilaginous fish MC2R orthologs
can be activated by either ACTH or MSH-related peptides, and the degree of dependence
on interaction with MRAP1 is species specific (Reinick et al. 2012, Dores et al. 2018,
Barney et al. 2019).
The initial question for this thesis project was whether the pharmacological
properties of esMC2R or srMC2R were more representative of the general pharmacological
properties of cartilaginous fish MC2R orthologs. Since the elephant shark is in subclass
Holocephali and the red stingray is in subclass Elasmobranchii (Figure 4), by analyzing the
pharmacological properties of additional holocephalan and elasmobranch MC2R
orthologs, it should be possible to address this issue. However the lack of available
holocephalan or elasmobranch MC2R and MRAP1 sequences, due to the rarity of these
species, created only more want for more information. Prior to 2017, the elephant shark
was the only complete cartilaginous fish genome available due to the inaccessibility of
tissue sample harvesting of holocephalans and elasmobranchs. However, in 2017 the
genome of the whale shark (Rhincodon typus) emerged as a potential model system for this
thesis. This species is another elasmobranch, but is a member of subclass Galeomorphii,
and rather distantly related to the red stingray, a member of subclass Batoidea. Annotation
of the genome revealed all five of the MCRs in addition to both MRAP paralogs. Thus,
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the first objective of this thesis was to express whale shark MC2R (wsMC2R) in
mammalian cells (CHO), and to test the hypothesis of whether wsMC2R has
pharmacological properties identical to those of elephant shark MC2R or red
stingray MC2R. In this section of the thesis, the sensitivity of wsMC2R to stimulation
with cartilaginous fish ACTH(1-24) and ACTH(1-13) amide (the non-acetylated form of
αMSH; Des-Acetyl-αMSH) in the presence and absence of co-expression with wsMRAP1
and wsMRAP2 was evaluated. Finally, the effect of co-expression of wsMC2R with
wsMRAP1 and wsMRAP2 with respect to the trafficking of the receptor to the plasma
membrane was evaluated.

Present Thesis Objectives: Part Two
Structure and function studies for human ACTH indicated that activation of the
“ACTH receptor” (i.e. MC2R) involves two amino acid motifs in the ACTH(1-24) region
of ACTH, the H6F7R8W9 motif and the K15K16R17R18 motif (Figure 5A; Schwyzer 1977).
Although the H6F7R8W9 motif is found in all melanocortin peptides and is required for
activation of all five melanocortin receptors (Cone 2006), the K15K16R17R18 motif is only
found in ACTH. The absence of this motif in MSH-sized ligands provides the rationale for
why α-MSH was not able to activate human MC2R (Mountjoy et al. 1992). As discussed
above, use of alanine-substituted analogs of human ACTH(1-24) (Figure 5B) confirmed
that the MC2R orthologs of multiple bony vertebrates require both the H6F7R8W9 motif
and the K15K16R17R18P19 motif for activation. Use of these analogs then would equally
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A

B
hACTH(1-24)

SYSMEHFRWGKPVGKKRRPVKVYP

AFRW

SYSMEAFRWGKPVGKKRRPVKVYP

HARW

SYSMEHARWGKPVGKKRRPVKVYP

HFAW

SYSMEHFAWGKPVGKKRRPVKVYP

HFRA

SYSMEHFRAGKPVGKKRRPVKVYP

A4

SYSMEAAAAGKPVGKKRRPVKVYP

AARRP

SYSMEHFRWGKPVGAARRPVKVYP

KKAAA

SYSMEHFRWGKPVGKKAAAVKVYP

A5

SYSMEHFRWGKPVGAAAAAVKVYP

KP

SYSMEHFRWGAAVGKKRRPVKVYP

ACTH(1-21)

SYSMEHFRWG---GKKRRPVKVYP

Figure 5. Key motifs within ACTH(1-24) impact stimulation of MC2R. A)
Motifs of interest within hACTH(1-24). The canonical H6F7R8W9 sequence is
necessary for activation of all MCRs. The K15K16R17R18 tetrabasic motif is of
interest for a potential proposed two-step activation mechanism. The ‘linker’
region between these two motifs is a focus due to the potential necessity of
proper positioning of them relative to each other. B) Alanine-substituted
analogs of hACTH(1-24). The hACTH(1-24) sequence was selectively
mutated or truncated in order to determine the relative importance of individual
residues and motifs.
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allow for analysis of the importance of three motifs of interest within ACTH(1-24) for
other MC2R orthologs: the melanocortin core sequence H6F7R8W9 (residues 6-9) which is
required for activation of all MCRs, the K15K16R17R18 (residues 16-19) motif which is
absolutely necessary for activation of the bony vertebrate MC2R orthologs, and the
G10K11P12V13G14 (residues 10-14) linker region between these motifs which likely plays an
important role in proper positioning of the H6F7R8W9 and K15K16R17R18 motifs relative to
each other (Figure 5B). The second objective of this thesis is to determine the activation
mechanism for the cartilaginous fish wsMC2R ortholog.
This portion of the present study will be accomplished by utilizing the same set of
alanine-substituted analogs of hACTH(1-24) (Figure 5B) which were used to characterize
the bony vertebrate MC2R orthologs. The hypothesis for this analysis is that the wsMC2R
ortholog will also require both the H6F7R8W9 motif and the K15K16R17R18 motif for
activation, indicative of a two-step activation mechanism consistent with the bony
vertebrate plan previously discussed.

Present Thesis Objective: Part Three
Previously it had been noted that within the human MC2R (hMC2R) there were ten
cysteine residues, nine of which are conserved among all of the human MCR orthologs
(Yang et al. 2007). In order to determine the role of these residues for the structure and
functioning of the hMC2R ortholog, these cysteine residues were systematically mutated
with serine residues and then analyzed for cell-surface expression, ACTH binding affinity
and ability to intracellularly signal, and measured by production of cAMP.
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Of the ten residues examined, the residues in the extracellular positions, C21 in the
N-terminal and C245, C251 and C253 in the EC3 were those determined to significantly
impact hMC2R functioning. When these residues were individually selectively mutated,
the cell surface expression of the mutated hMC2R ortholog was decreased to 48% (C21S),
56% (C245S), 46% (C251S) and 38% (C253S) of expression of the wild-type receptor
(Yang et al. 2007). Additionally, cAMP production was as decreased to 26% (C21S), 34%
(C245S), 25% (C251S) and 23% (C253S) of cAMP production of wild type hMC2R and
ACTH binding affinity for all mutant receptors was also significantly decreased (Yang et
al. 2007). In contrast, the other cysteine residues in the transmembrane domains or the
intracellular region of hMC2R did not affect the hMC2R ortholog functioning. Further
investigation revealed that the reason for the effect of the extracellular cysteine mutants on
hMC2R functioning is due to the importance of the formation of disulfide bonds which
contribute heavily to the receptor structure (Yang et al. 2007). This observation was in
congruence with determinations made about the necessity of a corresponding disulfide
bridge seen in the crystal structure of rhodopsin (Davidson et al. 1994).
From these previous observations it became interesting to observe whether the
wsMC2R would show similar characteristics to the hMC2R in regard to the necessity of
these congruent cysteine residues. The third objective of this thesis was to determine
whether key cysteine residues in the N-terminal and EC3 region were necessary for
optimal functioning of the wsMC2R ortholog.

The operating hypothesis for this

objective was that if the cysteine residues in these positions are necessary for key
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functioning of the wsMC2R ortholog, then when these residues are replaced with alanine
the receptor will show a dramatic decrease in normal function.

Present Thesis Objective: Part Four
The divergence of traits for bony vertebrate and cartilaginous fish MC2R orthologs
is not exclusive to ligand selectivity but also the different relationship with MRAP1. The
understood relationship between MRAP1 and bony vertebrate MC2R discussed above has
been further examined for mammalian MC2R orthologs which has clarified the logistics of
this interaction. Due to the unique reverse topology of the MRAP1 homodimer the first
aspect questioned was whether the activation motif of MRAP1 was interacting with MC2R
on the extracellular or intracellular side. Chimeric experiments which substituted either
the intracellular activation motif or the extracellular motif with alanine (Figure 6) revealed
that the activation motif on the extracellular side is the one necessary for activation of
mammalian MC2R (Malik et al. 2015). The results of this study suggest that MRAP1
interacts with MC2R at an extracellular loop. Later studies also implicated the extracellular
loops of hMC2R as important for activation. Activation of hMC2R was diminished when
the N-terminal region was replaced with that of hMC4R (Hinkle et al. 2011).
To address this further, another study sought to identify the region of mammalian
MC2R which is interacting with the MRAP1 homodimer. To do this, a series of chimeric
hMC2Rs were created which replaced either the N-terminal, EC1, EC2, or EC3 with the
corresponding amino acid sequences from the Xenopus tropicalis (xt) MC1R, a receptor
which is not dependent on MRAP1 (Dores et al. 2014, Davis 2018). The choice of xtMC1R
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as the sequence source for the chimerics was in part justified since the Hinkle et al. 2011
study predicted that the diminished receptor activity was potentially due to the difference
in length of the hMC2R and hMC4R N-terminal sequences; the xtMC1R N-terminal and
EC sequences were closer in size. This study revealed that the EC2 region is the most
likely point of interaction for mammalian MC2R, which was in agreement with previous
studies from other groups which also proposed EC2 as the potential region of interaction
(Fridmanis et al. 2010, Davis 2018). Earlier studies also introduced the suggestion that it
is not exclusively interaction with EC2, but the surrounding transmembrane domains
(TMs) as well, TM4 and TM5 (Davis et al. 2013, Liang et al. 2013, Dores et al. 2016, Dores
2018, Liang et al. 2018).

This led to experiments which performed single-alanine

mutations to residues within the TM4 and TM5 of hMC2R to observe the effect on hMC2R
trafficking (Davis 2018). This study revealed residues F168, H170, I163, and M165 within
TM4 and residues F178, L181 and F182 within TM5 as being important for trafficking of
MC2R (Davis 2018). The findings of this study informed the final objective of this
study which is to determine the region of the cartilaginous fish wsMC2R ortholog
which is responsible for the interaction with MRAP1. This will be pursued initially by
developing chimeric receptors which replace the extracellular regions of wsMC2R with the
correlated sequences from xtMC1R.
It is expected that the results of this portion of the study will match what was seen
for the hMC2R chimeric study. Thus the first operating hypothesis for this portion of the
present thesis is 1) wsMRAP1 is interacting with wsMC2R at the EC2 region. If this
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Figure 6. The activation motif on the extracellular side is necessary for
MC2R activation. Figure based on chimeric receptor studies performed by
Malik et. al (2015). Chimeric receptors which connected an MRAP1
homodimer to the MC2R ortholog allowed for study of importance of Nterminal region of MRAP1 for MC2R function. MC2R ortholog = gray,
MRAP1 homodimers = blue, N-terminal of MRAP1 = green, C-terminal of
MRAP1 = yellow, A) Mutation to N-terminal which faced the extracellular
side severely disrupted activation of MC2R, B) Mutation to N-terminal
which faced the intracellular side did not disrupt functioning of MC2R.
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hypothesis is supported, further investigation into this interaction will be performed
utilizing chimeric receptors which include a chimeric region from either TM4 or TM5. The
operating hypothesis for this second experimental approach is that 2) a TM region of
wsMRAP1 is interacting with a TM of wsMC2R in order to facilitate receptor trafficking
and activation. Chimeric receptors designed with sequences from xtMC1R will again be
used. The results of the chimeric study will inform further experiments which utilize either
cassette or single alanine mutations to the TMs which appear to be involved in the
wsMRAP1-wsMC2R interaction, in order to isolate the specific residues involved in the
interaction. Once the potential region of interaction has been narrowed as much as
possible, the final approach will be a selective mutation of individual residues by replacing
them with alanine in order to determine individual residues necessary for the wsMC2R
interaction with wsMRAP1. The operating hypothesis for this final approach is that select
residues are responsible for the interaction of wsMC2R and wsMRAP1, thus mutation of
the key residues will result in decreased functioning of the wsMC2R. Taken together, the
objectives of this thesis serve to more fully elucidate the activation mechanism and MRAP1
interaction of a representative cartilaginous fish MC2R, the wsMC2R.

21

CHAPTER 2: DETERMINATION OF WHALE SHARK MC2R AS AN
ACCEPTABLE MODEL FOR STUDY

Phylogenetic Classification of Cartilaginous Fish MC2R Orthologs
The previously mentioned characterizations of elephant shark and stingray MC2R
orthologs introduced that for cartilaginous fish, there appeared to be a spectrum of traits
regarding activation mechanism and dependence on MRAP1. However, prior studies left
open the question of whether the differences could be explained by phylogenetic
differences, since elephant shark (es) is a holocephalan cartilaginous fish (Callorhincus
milii; Family Callorinchidae, Order Chimaeriformes, Class Chondrichthyes, Phylum
Chordata) and the red stingray (sr) is an elasmobranch (Dasyatis akajei; Family
Dasyatidae, Order Myliobatiformes, Class Chondrichthyes, Phylum Chordata) (Figure 7).
Therefore, another model species to examine was sought in order to satisfy this concern.
Due to the recent publishing of genetic sequencing, the whale shark emerged as another
potential focus (Read et al. 2017). The whale shark (ws) is also an elasmobranch fish
(Rhincodon

typus;

Family

Rhincodontidae,

Order

Orectolobiformes,

Class

Chondrichthyes, Phylum Chordata) and presented as an ideal candidate due to the
annotated presence of all five melanocortin receptors (MC1R [XP_020390153.1], MC2R
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Figure 7. Phylogenetic relationship of cartilaginous fish. Cartilaginous fishes
(Chondrichthyans) are an important lineage for extant vertebrates. The
phylogeny of living Chondrichthyans is split into two subclasses: Elasmobranchii
(Elasmobranchs) and Holocephali (Holocephalans).
The subclass of
Elasmobranchii is further split to encompass Batoidea (rays and skates) and
Squalimorphii/Galeomorphii (sharks).
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(ACTH-receptor)

[XP_020380838.1],

MC3R

[XP_020372555.1],

MC4R

[XP_020379552.1], MC5R [XP_020385028.1]) within the genome, as well as both MRAP
paralogs (MRAP1 [XP_020375601.1], MRAP2 [XP_ 020377388.1]). A complete set of
orthologs was a marked improvement from the previously analyzed elasmobranch model,
the red stingray, on the basis that the stingray MRAP1 sequence has not yet been annotated.
The potential value of the whale shark ortholog as a model for further investigation of
characteristics of cartilaginous fish MC2Rs was then thoroughly analyzed in order to
develop adequate justification for future experiments.

Alignment and Comparison of Cartilaginous Fish MC2R Sequences and 3D Models
To determine the usefulness of wsMC2R as a representative model for studying
cartilaginous fish MC2Rs, an alignment of wsMC2R with the previously studied
cartilaginous fish MC2Rs was created (Figure 8). Analysis of the sequence homology
using the BLOSUM62 matrix (Blocks Substitution Matrix) within the ExPasy (Expert
Protein Analysis System) SIM local similarity program, the wsMC2R sequence was found
to be 59.3% homologous to the esMC2R sequence, and 64.5% homologous to the srMC2R
(Huang and Miller 1991). This high level of homology provided support for the use of
wsMC2R as a model for the cartilaginous fishes.
After the sequences were compared, another approach was taken to compare the
similarity of these structures. Utilizing the I-TASSER (Iterative Threading Assembly
Refinement) server software, three-dimensional virtual models of wsMC2R, esMC2R and
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Figure 8. Alignment of cartilaginous fish MC2R orthologs. Sequences for the
alignment were acquired from GenBank: wsMC2R (XM_020525249.1), esMC2R
(FAA704.1), srMC2R (LC108747). Bolded regions are representative of the TM
regions as determined by the TMHMM Server (DTU Health Tech, Denmark).
Residues which are identical in all three orthologs are represented in red.
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srMC2R were created (Roy et al. 2010, Yang et al. 2015, Yang and Zhang 2015, Zhang et
al. 2017).
The esMC2R model structure (Figure 9A) was generated utilizing various GPCR
template structures such as human MC4R (PDB ID: 6w25), human neuropeptide YY1
receptor (PDB ID: 5zbh) and the human melatonin receptor MT1 (PDB ID: 6me2). The
produced structure had a C-score of -1.06 and an RMSD (Root Mean Square Deviation)
value of 10.5 ± 4.6 Å. After finalization, the model which was then used for future
comparisons and analysis was found to be highly similar in structure to other rhodopsinlike GPCRs which supports confidence in the structure. The predicted similarity to the
established human MC4R crystal structure in particular was especially reassuring, with an
RMSD comparing the two structures of only 2.19 Å and a Cov score of 0.886 (Cov
represents the percentage of corresponding structurally aligned residues of the known
protein and query protein).
The srMC2R model structure (Figure 9B) also primarily utilized the human MC4R
crystal structure (PDB ID: 6w25) as a threading template, along with other GPCR such as
the human cannabinoid receptor CB1 (PDB ID: 5tgz) and the human alpha2c adrenergic
receptor (PDB ID: 6kuw). This structure had a C-score of -1.71 and an RMSD value of
10.5 ± 4.6 Å.

The final model matched most similarly to rhodopsin-like GPCRs,

supporting use of this structure. Additionally, there were multiple threading templates and
comparative structures in common for the esMC2R and srMC2R models which is
consistent with the sequence similarity between these proteins.
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Figure 9. 3D models of cartilaginous fish MC2R orthologs. The I-TASSER
server generates three-dimensional models of proteins based on their peptide
sequences by identifying regions of similarity within the unknown structure to
known threading templates. The regions of similarity are then used to develop
potential structures based on the known crystal structures of the matching
templates. These potential structures are then run through another algorithm
(SPICKER program) which compares the potential structures to each other in order
to determine the most likely structure for the unknown protein. The C-score is a
confidence interval for how closely the developed 3D structure matches known
structures. Ten different alignment programs are utilized on each potential model
to compare against all possible known structures (MUSTER, FFAS-3D, SPARKSX, HHSEARCH2, HHSEARCH1, Neff-PPAS, HHSEARCH, pGenTHREADER,
wdPPASS, PROSPECT2). A C-score closer to zero indicates highest confidence.
RMSD is based on the C-score as well as how closely the model relates to similar
known proteins which based on a TM (transmembrane domain) analysis algorithm
are predicted to have the most similar functions. For spatial reference: blue arrow
is pointing to the N-terminal, red arrow is pointing to the C-terminal, green arrow
is pointing to TM5. Direction of view faces directly at TM4-EC2-TM5 region of
MC2R ortholog. A) esMC2R, B) srMC2R, C) wsMC2R.
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Finally, the wsMC2R model structure (Figure 9C) utilized threading templates
which were similar to those used for the esMC2R and srMC2R models. Templates
included proteins such as the human cannabinoid receptor CB1 (PDB ID: 5tjv), the human
M4 muscarine receptor (PDB ID: 6kp6), and the human MC4R (PDB ID: 6w25). This
structure had a C-score of -1.57 and an RMSD value of 10.0 ± 4.6 Å. The finalized
structure was most similar to other rhodopsin-like GPCRs which helped establish
confidence in the use of the structure for preliminary analysis and comparison.
The models of the cartilaginous fish MC2R receptors: esMC2R, srMC2R and
wsMC2R were used in this study only as a preliminary comparative analysis tool in order
to explore potential avenues for proceeding with biochemical studies. To further compare
the wsMC2R to the previously studied cartilaginous fish MC2Rs, the developed threedimensional structures were compared to each other in order to compare the physical
similarities of the model structures in addition to the previously determined sequence
homology. Two different analyses were performed comparing wsMC2R to esMC2R
(Figure 10) and comparing wsMC2R to srMC2R (Figure 11): RMSD and BLOSUM60.
The RMSD analysis of wsMC2R and esMC2R revealed that these structures only differed
by a mean value of 26.7 Å and the RMSD analysis of wsMC2R and srMC2R revealed that
these structures only differed by a mean value of 28.6 Å. These values reflect a relatively
similar relationship between the structure of the orthologs as what was seen for the
sequence similarity (Figure 12), further supporting the relevance of these developed threedimensional models.

With all considerations taken together, the wsMC2R ortholog

appeared as a valuable model for a well-rounded study of the cartilaginous fish MC2Rs.
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Figure 10. RMSD and BLOSUM comparisons of wsMC2R and esMC2R
orthologs. A) RMSD analysis of overlayed wsMC2R and esMC2R. Utilizing the
STAMP Structural alignment in VMD, the 3D models were aligned and then colored
based on the RMSD value at each position; red = less similar, blue = more similar. B)
RMSD analysis of wsMC2R and esMC2R. Peaks represent the RMSD for each residue
position within the sequence of both orthologs relative to each other. Overall RMSD
for the structure is determined by an average of these values. C) BLOSUM analysis of
wsMC2R and esMC2R. After STAMP structural alignment, structures were colored
based on BLOSUM60 matrix analysis. BLOSUM60 is a series of matrices designed
to identify residues differing between different structures which are closely related in
order to predict residues which differ due to evolutionary change; red = less similar,
blue = more similar, D) Alignment of wsMC2R and esMC2R sequences with
associated BLOSUM60 colored analysis.
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Figure 11. RMSD and BLOSUM comparisons of wsMC2R and srMC2R
orthologs. A) RMSD analysis of overlayed wsMC2R and srMC2R. After STAMP
Structural alignment in VMD, the 3D models were aligned and then colored based
on the RMSD value at each position; red = less similar, blue = more similar. B)
RMSD analysis of wsMC2R and srMC2R. Peaks represent the RMSD for each
residue position within the sequence of both orthologs relative to each other. Overall
RMSD for the structure is determined by an average of these values. C) BLOSUM
analysis of wsMC2R and srMC2R. After STAMP structural alignment, structures
were colored based on BLOSUM60 matrix analysis. BLOSUM60 is a series of
matrices designed to identify residues differing between different structures which
are closely related in order to predict residues which differ due to evolutionary
change; red = less similar, blue = more similar, D) Alignment of wsMC2R and
srMC2R sequences with associated BLOSUM60 colored analysis.
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Figure 12. RMSD alignment of cartilaginous fish MC2R orthologs. Bolded
residues represent residues that are homologous among all three orthologs. From
RMSD analysis (VMD), the regions of least physical similarity are mainly the
N-terminal and C-terminal ends. This is consistent with the lack of homologous
residues in these regions. The other regions of higher dissimilarity are the IC3
and EC3 regions, especially of the srMC2R. Overall, there appears to be a
correlation between regions of similar residues and regions with similar threedimensional structure.
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Discussion
With the goal of more thoroughly analyzing the unique activation mechanism and
relationship with MRAP1 of the cartilaginous fish MC2R orthologs, the use of the
wsMC2R as a focus of study suggested valuable potential. From analyzing homology in
both the peptide sequence and the predicted three-dimensional structure between the
wsMC2R ortholog with the other cartilaginous fish MC2R orthologs, confidence was
established in use of the wsMC2R as a focus of study. Analysis of both peptide homology
(Figure 8) and RMSD between residues (Figure 12) of these three orthologs reveal both
consistent conservation as well as clear variability in some regions. The analysis overall
suggests that the wsMC2R may be more similar to the esMC2R in sequence and structure,
however all three orthologs are very similar. From this point, the next objective would be
addressed, which was to thoroughly characterize the wsMC2R ortholog in regard to ligand
selectivity, relationship with MRAP1 and activation mechanism.
The wsMRAP paralogs annotated within the whale shark genome: wsMRAP1
(Figure 13B; XP_020375601.1), and wsMRAP2 (Figure 13C; XP_020377388.1) were also
briefly analyzed prior to biochemical analyses. Both peptide sequences contained a
predicted transmembrane region and a necessary reverse topology motif, while only the
wsMRAP1 ortholog contained the predicted activation motif (Figure 13A).
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A

B

C

Figure 13. Structure and sequence of whale shark (Rhincodon typus)
MRAP1. A) Three-dimensional prediction of whale shark (ws) MRAP1.
C-score = -3.72. Visual model produced with Chimera software by UCSF.
B) Amino acid sequence of wsMRAP1 with denotation of select motif
relevance: activation relative motif = residues 32-35, reverse topology
motif = residues 40-46, transmembrane domain (as predicted by TMHMM
2.0 server by DTU Bioinformatics (DTU Health, Denmark)) = residues 4769 (Sebag and Hinkle 2007). C) Amino acid sequence of wsMRAP2 with
denotation of select motif relevance: reverse topology motif = residues 3541, transmembrane domain (as predicted by TMHMM 2.0 server by DTU
Bioinformatics (DTU Health, Denmark)) = 42-64.
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CHAPTER 3: PHARMACOLOGICAL CHARACTERIZATION OF
WHALE SHARK MC2R

Analysis of wsMC2R Dependence on wsMRAP1 for Activation and Trafficking
Once the sequences for the receptors and accessory proteins had been determined,
it became necessary to characterize the basic traits of the wsMC2R ortholog in order to
compare it to the cartilaginous fishes previously studied. When wsMC2R is co-expressed
with wsMRAP1, activation by srACTH(1-24) is increased 10,000-fold with an EC50 value
of 2.6 x 10-10 M ± 9.7 x 10-11 M (Figure 14A; t-test; p = 0.001). Additionally, wsMC2R
expressed alone was able to be stimulated by srDes-Acetyl-αMSH at concentrations of 1 x
10-6 M and 1 x 10-7 M, but when co-expressed with wsMRAP1 sensitivity to srDes-AcetylαMSH was increased 100-fold with an EC50 value of 4.2 x 10-9 M ± 2.2 x 10-9 M (Figure
14B; t-test; p = 0.001). In addition to the increase in receptor ligand sensitivity, coexpression with wsMRAP1 also significantly increased receptor trafficking to the cell
surface 7-fold (Figure 14E; One-way ANOVA/Dunnett’s post-hoc; p = 0.003).
It was also valuable to ascertain the relationship of wsMC2R with the wsMRAP2
ortholog, and when co-expressed with wsMRAP2 the sensitivity of wsMC2R to
srACTH(1-24) was increased approximately 1000-fold, with an EC50 value of
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Figure 14. Relationship of wsMC2R with wsMRAP1 and wsMRAP2. Figure
modified from Hoglin et al. 2020. Data points represented as mean ± SEM (n = 3).
Significance set at p < 0.05. A) Stimulation of wsMC2R ± wsMRAP1 with
srACTH(1-24). B) Stimulation of wsMC2R ± wsMRAP1 with srDes-AcetylαMSH. C) Stimulation of wsMC2R ± wsMRAP2 with srACTH(1-24). D)
Stimulation of wsMC2R ± wsMRAP2 with srDes-Acetyl-αMSH. E) Cell surface
expression of wsMC2R ± wsMRAP1/wsMRAP2. When co-expressed with either
wsMRAP1 or wsMRAP2, surface expression of wsMC2R was significantly
increased (One-way ANOVA/Dunnett’s post-hoc; p = 0.003, p < 0.0001).
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5.9 x10-9 M + 9.6 x10- 10 M (Figure 14C; t-test; p = 0.39). Co-expression with wsMRAP1
also caused a 100-fold increased sensitivity to srDes-Acetyl-αMSH (Figure 14D; EC50 =
5.5 x 10-8 M ± 2.2 x 10-8 M; t-test; p = 0.85 ). For cell-surface trafficking, co-expression
with wsMRAP2 had an even more dramatic effect, causing a 15-fold increase in receptor
surface expression (Figure 14E; One-way ANOVA; p < 0.0001).

Characterization of Activation Mechanism of wsMC2R
In addition to comparing the interaction of wsMC2R and its associated MRAP
paralogs to those of the other cartilaginous fish previously studied, determination of the
activation mechanism would allow for a more thorough comparison of these orthologs and
their qualities. The same set of alanine-substituted and truncated analogs of hACTH(1-24)
(Figure 15A) utilized to analyze the activation mechanisms of other vertebrate MC2R
orthologs were also used in this study in order to elucidate a proposed activation
mechanism for wsMC2R. Prior to use of the analogs it was determined that there was no
significant difference between stimulation with hACTH(1-24) and srACTH(1-24) (Figure
15B; t-test; p = 0.34).
Starting with the analogs which substituted residues within the canonical H6F7R8W9
“activation motif” (Gallo-Payet and Battista 2014), it was seen that single-alanine
substitution to the H6 or F7 residues (AFRW, HARW analogs) did not cause a significant
decrease in sensitivity to stimulation by srACTH(1-24) with EC50 values of 4.4 x 10-9 M ±
1.2 x 10-10 M and 2.6 x 10-9 M ± 1.7 x 10-10 M respectively, compared to control hACTH(1-
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Figure 15. Alanine-substituted analogs. A) Table of alanine-substituted analogs
of hACTH(1-24) utilized to predict the activation mechanism of wsMC2R. B)
Comparison of activation of wsMC2R with srACTH(1-24) and hACTH(1-24).
Data points represented as mean ± SEM (n = 3). Significance set at p < 0.05. When
stimulated with srACTH(1-24) wsMC2R had an EC50 value of 8.6 x 10-10 M ± 2.1
x 10-10 M. When stimulated with hACTH(1-24) wsMC2R had an EC50 value of 4.4
x 10-10 M ± 2.0 x 10-10 M.
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24) (Figure 16A; EC50 = 1.1 x 10-9 M ± 3.3 x 10-10 M; One-way ANOVA/Tukey’s posthoc; p = 0.76, 0.86). Single-alanine substitutions to the R8 or W9 residues (HFAW, HFRA
analogs) resulted in EC50 values of 9.7 x 10-8 M ± 4.6 x 10-8 M and 6.2 x 10-8 M ± 9.3 x 109

M (One-way ANOVA/Tukey’s post-hoc; p = 0.51, p = 0.50). When the level of activation

at a peptide concentration of 1 x 10-8 M was compared, stimulation by the HFAW and
HFRA peptides was significantly less compared to control hACTH(1-24) (Figure 16B
(inset); One-way ANOVA/Tukey’s post-hoc; p < 0.0001, < 0.0001). Full-motif alaninesubstitution (A4 analog) resulted in no stimulation of wsMC2R (Figure 16A). These
discoveries regarding the importance of the H6F7R8W9 motif for activation of the
cartilaginous fish MC2Rs were not surprising, since this motif is necessary for activation
of all melanocortin receptors (Schwyzer 1977).
It has been previously observed that removal of the K15K16R17R18 motif of ACTH
resulted in no stimulation of rat adrenal cells (Schwyzer 1977), which led to the conclusion
that mammalian ACTH receptors require not only the H6F7R8W9 motif, but also the
K15K16R17R18 motif for activation. To test the hypothesis that wsMC2R would require both
the H6F7R8W9 and K15K16R17R18 motifs for activation, the stimulation of wsMC2R with
alanine-substituted analogs which affected the K15K16R17R18P19 region of hACTH(1-24)
were used.
Study of the effect of the K15K16R17R18P19 analogs (Figure 16C, 16D) on activation
of the wsMC2R furthered this observation of a variation in traits. Stimulation with the
analogs AARRP or KKAAA both caused 100-fold decreases in activation compared to
stimulation with control hACTH(1-24) (EC50 = 5.5 x 10-10 M ± 1.8 x 10-10 M).
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Figure 16. wsMC2R stimulated with alanine-substituted analogs. Data points
represented as mean ± SEM (n = 3). Significance set at p < 0.05. A) wsMC2R
stimulated by AFRW, HARW and A4 analogs. B) Stimulation with HFAW and
HFRA analogs. C) Stimulation with AARRP, KKAAA and A5 analogs. Stimulation
with AARRP had an EC50 value of 1.6 x 10-8 M ± 1.6 x 10-9 M (One-way
ANOVA/Tukey’s post-hoc; p = 0.93) and stimulation with KKAAA had an EC50 value
of 1.9 x 10-8 ± 3.8 x 10-9 M (One-way ANOVA/Tukey’s post-hoc; p = 0.99).
Stimulation with the A5 analog had an EC50 value of 7.4 x 10-7 M ± 1.0 x 10-7 M;
One-way ANOVA/Tukey’s post-hoc; p = 0.54). D) Stimulation with KP and
ACTH(1-21) analogs. When compared at a peptide concentration of 1 x 10-9 M, the
ACTH(1-21) analog did not significantly decrease activation compared to control
hACTH(1-24) (One-way ANOVA/Tukey’s post-hoc; p = 0.12).
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When comparing the level of activation at a peptide concentration of 1 x 10-9 M, stimulation
with the AARRP, KKAAA and A5 analogs was significantly decreased compared to
control hACTH(1-24) (Figure 16C (inset); One-Way ANOVA/Tukey’s post-hoc; p <
0.0001, p < 0.0001, p < 0.0001). Full-motif substitution (A5 analog) caused a 1000-fold
decrease in ligand sensitivity (Figure 16C).
The final aspect of the sequence and structure of hACTH(1-24) which would be
beneficial to understanding the activation mechanism of wsMC2R is the structure of the
linker region between the H6F7R8W9 and K15K16R17R18 motifs.

This linker region,

G10K11P12V13G14 likely plays an important role in correct positioning of the two motifs
relative to each other at the binding sites on the receptor. Perturbation then would likely
disrupt stimulation of receptors which require both for activation. Thus, these analogs
either substituted a portion of the linker region with alanine (KP analog) or removed the
key glycine residues (ACTH(1-21) analog), the latter of which affecting the length and
flexibility of the linker region.
When compared at a peptide concentration of 1 x 10-8 M, the KP analog was
significantly less than control hACTH(1-24) (Figure 16D (inset) One-way ANOVA; p =
0.0003). This analog had an EC50 value of 5.6 x 10-10 M ± 1.8 x 10-10 M; (Figure 16D;
One-way ANOVA/Tukey’s post-hoc; p = 0.76) compared to control (EC50 = 7.9 x 10-10 M
± 5.5 x 10-10 M). The ACTH(1-21) did not cause a significant decrease (Figure 16D; EC50
= 2.4 x 10-9 M ± 2.8 x 10-10 M; One-way ANOVA/Tukey’s post-hoc; p = 0.79) compared
to control hACTH(1-24).
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Discussion
The stimulation of wsMC2R with either srACTH(1-24) or srDes-Acetyl-αMSH
revealed that both ligands were able to stimulate wsMC2R. Notably, the wsMC2R was
much more effectively stimulated by srACTH(1-24), nearly 100-fold more sensitive to
stimulation with srACTH(1-24) than srDes-Acetyl-αMSH.

This introduced the first

instance where the characteristics of the wsMC2R ortholog present more as a bridge
between the previously identified characteristics of other cartilaginous fish MC2R
orthologs and bony vertebrate MC2R orthologs. The esMC2R can be stimulated by either
ACTH or MSH-sized ligands with essentially equal potency (Barney et al. 2019), bony
vertebrate MC2Rs can only be stimulated by ACTH (Dores and Garcia 2015), and
wsMC2R, like srMC2R (Dores et al. 2018) can be stimulated by either ACTH or MSHsized ligands, but with statistically higher sensitivity for ACTH (Figure 14).
Further analysis of the relationship of wsMC2R with wsMRAP1 continued to
suggest that the wsMC2R ortholog occupies a place on a spectrum of traits among
vertebrate MC2Rs. This opposed the previous dichotomous comparison of cartilaginous
fish MC2R orthologs and bony vertebrate MC2R orthologs. The wsMC2R ortholog
represents a third pattern of relationship for MC2R with MRAP1, suggesting a spectrum
rather than tightly defined groups. For esMC2R, MRAP1 is not necessary for activation,
but does slightly enhance sensitivity to stimulation by srACTH(1-24) (Barney et al. 2019).
For srMC2R, while some level of activation is achieved alone, the presence of esMRAP1
appears to rescue the activation of this receptor (Dores et al. 2018). Therefore, the
wsMC2R ortholog and the srMC2R ortholog respond in a very similar manner to co41

expression with MRAP1. Neither receptor is physiologically relevant when expressed
alone, and both receptors express in a manner distinct from the esMC2R ortholog. This
loose pattern among cartilaginous fishes potentially suggests that there was a distinct split
in traits between holocephalan and elasmobranch fishes, with an evolution of a spectrum
within subclasses.
This characterization of wsMC2R further indicated that this analog would be an
excellent candidate for further analysis of the MC2R-MRAP1 interaction in cartilaginous
fishes.

The unique aspect of the analysis of the wsMC2R ortholog is the unique

relationship of wsMC2R with the wsMRAP2 ortholog. Unlike other bony vertebrate
MC2R orthologs, the presence of wsMRAP2 greatly increased trafficking.
Based on the results of the alanine-substituted analogs study, as well as the previous
characterization which showed that wsMC2R is able to be activated by srDes-AcetylαMSH, it is likely that the activation mechanism for wsMC2R is able to function in either
a one- or two-step mechanism. These two type of mechanism were discussed previously,
where bony vertebrates require a two-step activation mechanism involving initial binding
of the K15K16R17R18P19 motif (the “address motif”) in order for the H6F7R8W9 motif to have
access and lead to receptor activation, and MSH-sized ligands cannot activate bony
vertebrate MC2R orthologs because of the absence of the “address motif.” In contrast, the
esMC2R ortholog effectively adopts a one-step preferred activation mechanism where the
H6F7R8W9 motif has readily available access to its binding site, leading to receptor
activation, and the K15K16R17R18P19 motif does not play a role in activation (Hoglin et al.
2019). Since wsMC2R is able to be activated by srDes-Acetyl-αMSH, but alanine
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substitutions to the K15K16R17R18P19 motif caused dramatic decreases in receptor
stimulation it is proposed that the two-step activation mechanism is the preferred
mechanism for wsMC2R, possibly leading to a more open H6F7R8W9 binding site when
the K15K16R17R18P19 motif binds first, but that the H6F7R8W9 binding pocket of wsMC2R
is not fully closed as is understood for the bony vertebrate MC2R orthologs, which allows
activation of wsMC2R with peptides lacking or having altered K15K16R17R18P19 regions
(Figure 17).
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Figure 17. Predicted two-step activation mechanism. Figure adapted from Hoglin
et al. 2019. In this cartoon, in the “off” position the MC2R ortholog has an open
binding pocket available for the K15K16R17R18 motif. Once ligand is available, the
K15K16R17R18 motif binds to this available pocket (1) which then leads to a
conformational change in the receptor. This action effectively “opens” the binding
pocket for the H6F7R8W9 motif and binding of the H6F7R8W9 motif subsequently
leads to receptor activation (2).

44

CHAPTER 4: IDENTIFICATION OF KEY CYSTEINE RESIDUES IN
EXTRACELLULAR LOOPS OF WHALE SHARK MC2R

Importance of Key Cysteine Residues for Structure and Function of MC2R orthologs
Previous studies on hMC2R revealed that of the ten cysteine residues located in the
extracellular portions of the receptor, mutation of three of these residues specifically located in the N-terminal (NT) domain and extracellular loop 3 (EC3), caused a significant
disruption in the ability of ACTH to interact with the receptor (Yang et al. 2007). This
outcome is predicted to be the result of formation of a disulfide bond between the cysteines
in the NT and EC3 which contribute to the formation of the peptide binding pocket
structure. It was of interest to determine whether the same observations seen for hMC2R
would be true also for the wsMC2R.
In order to analyze this trait in wsMC2R, a chimeric receptor approach was taken.
This method was chosen based on a previous study which utilized chimeric hMC2Rs
(Davis 2018). In this study a chimeric receptor paradigm was used to test the hypothesis
that one or more of the extracellular domains in hMC2R interacts with MRAP1 to facilitate
the activation of hMC2R. An alignment of hMC2R with Xenopus tropicalis MC1R
(xtMC1R) indicated low primary sequence identity between the extracellular domains of
the two receptors, which seemed a good rationale for using chimeric hMC2R/xtMC1R
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receptors to test this hypothesis. However, the absence of a cysteine residue in the Nterminal domain of xtMC1R at position 31, and the absence of a cysteine residue in the
EC3 domain of xtMC1R resulted in chimeric receptors (i.e. hMC2R w/xtMC1R NT and
hMC2R w/xtMC1R EC3) that could not be activated. When the chimeric receptors were
re-designed with cysteine residues in the appropriate positions, the chimeric receptors were
able to be activated, and as a result both the N-terminal domain and the EC3 domain were
eliminated as potential contact sites between hMC2R and MRAP1 (Davis 2018). Based
on these observations, the present study tested the hypothesis that the cysteine residue in
the N-terminal domain and two cysteine residues in the EC3 domain of wsMC2R are
required for the activation of wsMC2R.
To begin this investigation, three-dimensional models were created for the
following relevant chimeric receptors: wsMC2R with the WT xtMC1R NT region (no
added cysteine), wsMC2R with the xtMC1R NT region with an added cysteine at position
48 (C48), wsMC2R with the WT xtMC1R EC3 region (no added cysteines), and wsMC2R
with the xtMC1R EC3 region with added cysteines at positions 287 and 290 (C287, C290).
These models were created utilizing the I-TASSER software server (Roy et al. 2010, Yang
et al. 2015, Yang and Zhang 2015, Zhang et al. 2017).
Looking first at the N-terminal chimerics, the model which did not include an added
cysteine residue (xtMC1R NT chimeric) had a C-score of -0.61 and an RMSD value of 7.6
± 4.3 Å. Interestingly, when compared to wild type wsMC2R, this model had a mean
difference of 27.39 Å (Figure 18A). This is in contrast to the model which included the
C48 residue (Figure 18E; xtMC1R NT + C chimeric), which had a C-score of -0.82 and
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an RMSD value 8.2 ± 4.5 Å, but when compared to wild-type wsMC2R only showed a
mean difference of 15.41 Å (Figure 18B). This suggested that the chimeric receptor with
the added cysteine residues would be more functionally similar to wsMC2R, however
further biochemical studies would be required to confirm this suspicion. Due to the similar
threading templates and protein structures determined to be most structurally similar to the
developed models, these chimerics were determined to be likely useful for future
biochemical analysis.
Focusing attentions then on the EC3 region chimerics, the model of the chimeric
which replaced EC3 with the corresponding region from xtMC1R but did not include the
added cysteine residues (xtMC1R EC3 chimeric) had a C-score of -0.16 and an RMSD
value of 6.8 ± 4.0 Å. When compared to wsMC2R this model had a mean difference of
15.69 Å (Figure 18C). The corresponding model which had the EC3 region replaced with
the EC3 region from xtMC2R but also the added cysteine residues (Figure 18F; xtMC1R
EC3 + C chimeric; C287, C290) had a C-score of -0.43 and an RMSD value of 7.4 ± 4.2
Å. Compared to wild type wsMC2R the mean difference was 15.16 Å (Figure 18D), which
was close but slightly less than the chimeric receptor lacking the additional cysteines.
Evaluating the threading templates for this residue also approved of its use for further
biochemical study.
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Figure 18. 3D models of wsMC2R/xtMC1R chimerics with added cysteine
residues. RMSD comparisons of: A) wsMC2R w/xtMC1R NT (No C)
chimeric & WT wsMC2R, B) wsMC2R w/xtMC1R NT + C48 chimeric & WT
wsMC2R, C) wsMC2R w/xtMC1R EC3 (No C) chimeric & WT wsMC2R, D)
wsMC2R w/xtMC1R EC3 + C287/C290 chimeric & WT wsMC2R, E)
wsMC2R with xtMC1R NT region (cyan). Modified cysteine residue at
position 48 (C48) in red. Model structure was related most closely to proteins
such as the human cannabinoid receptor (PDB ID: 5tjv), the human M4
muscarine receptor (PDB ID: 6kp6) and the human MC4R (PDB ID: 6w25). F)
wsMC2R with xtMC1R EC3 region (cyan). Modified cysteine residues (C287
and C290) in red. Model structure was related most closely to proteins such as
a human GPCR (PDB ID: 5zty), the human B2 adrenergic GPCR (PDB ID:
2rh1), and the human MC4R (PDB ID: 6w25).
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Effect of Key Cysteine Residues on Activation of wsMC2R
The first chimerics addressed were the xtMC1R NT chimerics with or without the
added key cysteine residues. When stimulated with srACTH(1-24), the xtMC1R NT
chimeric with no added cysteine showed complete diminishment of activation (Figure 19A)
compared to control wsMC2R (EC50 = 1.6 x 10-10 M ± 4.0 x 10-11 M). With the added
cysteine residue (C48), activation by srACTH(1-24) was recovered to an EC50 value of 7.7
x 10-10 M ± 2.2 x 10-10 M, which was not significantly different from control wsMC2R (ttest; p = 0.74). When these chimerics were stimulated with srDes-Acetyl-αMSH, the
xtMC1R NT chimeric with no cysteine residue also showed complete diminishment of
activation compared to control wsMC2R (EC50 = 1.5 x 10-8 M ± 8.1 x 10-9 M). With the
addition of the cysteine residue (C48) however, activation was only recovered to
stimulation at a peptide concentration of 1.0 x 10-6 M (Figure 19B).
Looking then at the xtMC1R EC3 chimerics, when stimulated with srACTH(1-24)
the chimeric lacking the cysteine residues showed complete diminishment of receptor
activation compared to control wsMC2R (Figure 19C; EC50 = 9.9 x 10-10 M ± 5.9 x 10-10
M). With the added cysteine residues (C287, C290), activation by srACTH(1-24) was
recovered to an EC50 value of 6.18 x 10-8 M ± 2.3 x 10-8 M, which was not significantly
different from wsMC2R (t-test; p = 0.38). When stimulated with srDes-Acetyl-αMSH
(Figure 19D), the chimeric lacking the cysteine residues also showed a complete lack of
receptor activation. Control wsMC2R had an EC50 value of 14 x 10-8 M ± 5.0 x 10-9 M,
and while the added cysteine residues (C287, C290) partially recovered activation,
stimulation was only seen at a peptide concentration of 1.0 x 10-6 M.
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Figure 19. Activation of cysteine-modified chimeric receptors. Data points
represented as mean ± SEM (n = 3). Significance set at p < 0.05. A) xtMC1R NT
Chimerics stimulated with srACTH(1-24). B) xtMC1R NT Chimerics stimulated
with srDes-Acetyl-αMSH. C) xtMC1R EC3 Chimerics stimulated with srACTH(124). D) xtMC1R EC3 chimerics stimulated with srDes-Acetyl-αMSH.
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Effect of Key Cysteine Residues on Trafficking of wsMC2R
To further analyze the importance of these cysteine residues, the effect on
trafficking was observed. As expected, based on the activation assays, the chimerics with
the xtMC1R NT and EC3 regions lacking the cysteine residues displayed significantly
reduced cell-surface expression compared to control wsMC2R (Figure 20; 0.58 ± 0.08
Lumens/pixel; One-way ANOVA/Dunnett’s post-hoc; p < 0.0001, p < 0.0001). The
xtMC1R NT chimeric had a mean fluorescence of 0.02 ± 0.08 Lumens/pixel and the
xtMC1R EC3 chimeric had a mean fluorescence of 0.12 ± 0.05 Lumens/pixel (Figure 20).
With the cysteine residues added, the xtMC1R NT + C chimeric had a mean fluorescence
of 0.84 ± 0.06 Lumens/pixel, which was increased compared to wsMC2R (One-way
ANOVA/Dunnett’s post-hoc; p = 0.05). The xtMC1R EC3 + C chimeric also showed a
dramatic recovery, with a mean fluorescence of

0.90 ± 0.09 Lumens/pixel, also

significantly greater than wsMC2R (Figure 20; One-way ANOVA/Dunnett’s post-hoc; p
= 0.01).
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Figure 20. Immunofluorescent cell-surface imaging of cysteine chimerics. A)
Cell-surface imaging of wsMC2R and xtMC1R NT/EC3 chimerics. Images on nonpermeabilized cells. All receptor constructs were expressed with wsMRAP1.
xtMC1R NT chimeric (2nd row) was expressed at very low levels, but the added
cysteine residue at position 48 (xtMC1R NT + C chimeric; 3rd row) rescued
expression. Similarly, the xtMC1R EC3 chimeric was barely expressed, but with the
added cysteines at positions 287 and 290 (xtMC1R EC3 + C chimeric) expression
was rescued. Images show maximum z projections. Scale bar = 1μm. B) Analysis
of mean fluorescence. Data sets represented as mean ± SEM (n = 50). Significance
set at p < 0.05.
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Discussion
For the wsMC2R ortholog, lack of key cysteine residues at position 48 in the Nterminal region and positions 287 and 290 in the EC3 region caused a dramatic decrease in
functionality of the receptor. Both trafficking and activation were negatively impacted by
the replacement of either the N-terminal or EC3 domain with the corresponding region of
xtMC1R which lacked the cysteine residues. However, additional mutation of these
sequences adding the necessary cysteine residues to the chimeric receptors restored
function. Taken together these results suggest that for the wsMC2R ortholog, these key
cysteine residues are important for the formation of disulfide bonds which provide
necessary structure to the overall binding pocket structure of the wsMC2R ortholog. This
is consistent with the results seen for similar studies on the hMC2R ortholog, suggesting
that this characteristic is potentially salient for both cartilaginous fish and bony vertebrate
MC2R orthologs.
The results of this present study supported the hypothesis that the cysteine residues
in the N-terminal and EC3 regions of wsMC2R are necessary for the activation of
wsMC2R. Additionally, these results excluded either the N-terminal or the EC3 region of
wsMC2R as being the potential site of interaction between wsMC2R and wsMRAP1, since
the chimeric receptors, after the key cysteines were added, were still able to be activated at
physiologically relevant concentrations of peptide.
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CHAPTER 5: IDENTIFICATION OF EXTRACELLULAR REGION OF
INTERACTION FOR WHALE SHARK MC2R AND MRAP1

Interaction of wsMRAP1 N-terminal with Extracellular Region of wsMC2R
Previous studies of the interaction between hMC2R and hMRAP1 strongly
implicated extracellular loop 2 (EC2) as the region where these proteins interact (Davis
2018). Taking this into consideration, the analysis of extracellular domains and their
potential role in the activation of wsMC2R using the wsMC2R/xtMC1R chimeric receptor
paradigm, previously shown in chapter 4, now focused on the EC2 domain of wsMC2R.
To determine whether this is the necessary region for interaction between wsMC2R and
wsMRAP1, a chimeric receptor was designed which replaced the EC2 region of wsMC2R
with the corresponding region from the xtMC1R. The xtMC1R was chosen as the source
for the alien residues since this receptor does not require an MRAP1 homologue for
receptor activation or trafficking. Additionally, the xtMC1R had precedingly been used in
similar studies for hMC2R (Davis 2018).
Since the previous chapter revealed that a chimeric substitution of either the Nterminal or EC3 region of wsMC2R did not prevent the receptor from interacting with
wsMRAP1, the only extracellular region of wsMC2R left to address was extracellular loop
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1 (EC1). A chimeric receptor which replaced the EC1 region of wsMC2R with the
corresponding region of xtMC1R was utilized for this analysis.

Modeling of a wsMC2R/xtMC1R EC2 Chimeric
To further address whether the xtMC1R EC2 chimeric would be a good candidate
for use in activation and trafficking assays, a three-dimensional model of the chimeric was
created (Figure 21A) utilizing the I-TASSER software server (Roy et al. 2010, Yang et al.
2015, Yang and Zhang 2015, Zhang et al. 2017). The produced model had a C-score of .01 and an RMSD value of 6.4 ± 3.9 Å, which suggested confidence that this specific
chimeric would not be prematurely degraded. Additionally, the threading templates and
most similarly matched proteins for the final structure closely resembled those for the WT
wsMC2R. This model was then compared using a VMD (Visual Molecular Dynamics)
analysis to the previously discussed WT wsMC2R model to determine the RMSD value
between them, which was found to be 2.4 Å. Precursory analyses of the predicted model
suggested that it would be productive moving forward with biochemical analysis.

Analysis of Activation of wsMC2R/xtMC1R EC2 Chimeric by ACTH and MSH
When stimulated with srACTH(1-24), the xtMC1R EC2 chimeric did not cause a
significant decrease in sensitivity to stimulation by srACTH(1-24) (EC50 = 9.4 x 10-10 M ±
1.7 x 10-10 M) as compared to wild-type wsMC2R, which had an EC50 value of 2.7 x 10-10
M ± 4.5 x 10-11 M (Figure 21B; t-test; p = 0.93). Similarly, there was also no significant
decrease in sensitivity when the xtMC1R EC2 chimeric was stimulated with srDes-Acetyl55

αMSH, which had an EC50 value of 5.2 x 10-8 M ± 2.2 x 10-8 M compared to wild-type
wsMC2R (Figure 21C; EC50 = 3.9 x 10-9 M ± 1.2 x 10-9 M; One-way ANOVA/Tukey’s
post-hoc; p = 0.94).
Taken together, these results suggest that the EC2 region of wsMC2R is likely not
the primary location of interaction for wsMC2R and wsMRAP1. In particular regard to
the stimulation of wsMC2R by either srACTH(1-24) or srDes-Acetyl-αMSH, mutation to
the EC2 region did not appear to inhibit wsMC2R activation. This is unlike the previously
studied hMC2R/MRAP1 interaction, which implicated the EC2 region as necessary for
activation of hMC2R.

Imaging of Cell Surface Expression of wsMC2R/xtMC1R EC2 Chimeric
To further assess the potential role of the EC2 region of wsMC2R with wsMRAP1,
the other aspect of the MC2R-MRAP1 relationship, trafficking, was addressed. This was
done by comparing the cell-surface expression of the wsMC2R/xtMC1R EC2 chimeric
with the cell-surface expression of wild-type wsMC2R (Figure 21D). The chimeric
receptor had a mean fluorescence of 1.5 ± 0.09 Lumens/pixel compared to wsMC2R
(Figure 21E; 1.2 ± 0.09 Lumens/pixel; One-way ANOVA/Dunnett’s post-hoc; p = 0.01).
The chimeric receptor did not appear to impede trafficking. There was not a decrease in
cell-surface expression of the chimeric receptor, further emphasizing that the N-terminal
domain of wsMRAP1 does not appear to interact with the EC2 region of wsMC2R. This
implicates that wsMRAP1 does not facilitate activation of wsMC2R at the EC2 region, and
additionally, substitution of the
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Figure 21. Analysis of xtMC1R EC2 chimeric modeling, activation and
trafficking A) 3D model of the xtMC1R EC2 chimeric (EC2 region in red). Model
was most closely related to proteins such as the human cannabinoid receptor CB1
(PDB ID: 5tgz) and human B2-adrenergic GPCR (PDB ID: 2rh1). B) Stimulation
of xtMC1R EC2 chimeric with srACTH(1-24). Data points represented as mean ±
SEM (n = 3). Significance set at p < 0.05. C) xtMC1R EC2 chimeric with srDesAcetyl-αMSH. Data points represented as mean ± SEM. Significance set at p <
0.05. D) Immunofluorescent cell-surface imaging of wsMC2R and xtMC1R EC2
chimeric. Images of non-permeabilized cells. All receptor constructs were
expressed with wsMRAP1. The xtMC1R EC2 chimeric (2nd row) was expressed at
levels not significantly different from control. Images show maximum z
projections. Scale bar = 1μm. E) Analysis of mean fluorescence. Data sets
represented as mean ± SEM (n = 50). Significance set at p < 0.05.
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EC2 domain does not interfere with wsMRAP1-mediated trafficking of wsMC2R to the
plasma membrane.

Modeling of a wsMC2R/esMC3R EC2 Chimeric
In order to further confirm any potential interaction between wsMRAP1 and the
extracellular regions of wsMC2R, an additional EC2 chimeric receptor was created in the
same manner as the xtMC1R EC2 chimeric previously mentioned. This time however, the
corresponding extracellular region for EC2 from the esMC3R receptor was used to replace
the wsMC2R EC2. This receptor was chosen in order to create a chimeric with a receptor
that was still not dependent on MRAP1, but also had the similarity of being from another
cartilaginous fish receptor.
Once again, a three-dimensional model of the wsMC2R/esMC3R EC2 chimeric
was created for a precursor analysis utilizing the I-TASSER software server (Roy et al.
2010, Yang et al. 2015, Yang and Zhang 2015, Zhang et al. 2017). This model had a Cscore of -1.47 and an RMSD-value of 9.8 ± 4.6 Å (Figure 22A), suggesting that this protein
would not be prematurely degraded. The chimeric model was then compared to the WT
wsMC2R model using a VMD analysis of RMSD which determined that the mean
difference between the structures was 11.3 Å. Taken together, this preliminary virtual
analysis suggested productive use of this chimeric receptor for further biochemical study.
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Figure 22. Analysis of esMC3R EC2 chimeric modeling, activation and
trafficking A) 3D model of the esMC3R EC2 chimeric (EC2 region in red). Model
was most closely related to proteins such as a human GPCR (PDB ID: 5zty) and the
human MC4R (PDB ID: 6w25). B) Stimulation of esMC3R EC2 chimeric with
srACTH(1-24). Data points represented as mean ± SEM. Significance set at p < 0.05.
C) Stimulation of esMC3R EC2 chimeric with srDes-Acetyl-αMSH. Data points
represented as mean ± SEM (n = 3). Significance set at p < 0.05. D)
Immunofluorescent cell-surface imaging of wsMC2R and esMC3R EC2 chimeric.
Images of non-permeabilized cells. All receptor constructs were expressed with
wsMRAP1. The esMC3R EC2 chimeric (2nd row) was expressed at levels not
significantly different from control. Images show maximum z projections. Scale bar
= 1μm. E) Analysis of mean fluorescence. Data sets represented as mean ± SEM (n
= 50). Significance set at p < 0.05. Data points represented as mean ± SEM.
Significance set at p < 0.05.
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Analysis of Activation of wsMC2R/esMC3R EC2 Chimeric by ACTH and MSH
When stimulated with srACTH(1-24), the esMC3R EC2 chimeric did not cause a
significant decreased in sensitivity with an EC50 value of 1.9 x 10-10 M ± 1.5 x 10-10 M as
compared to wild type wsMC2R (Figure 22B; EC50 = 1.0 x 10-10 M ± 3.2 x 10-11 M; OneWay ANOVA/Tukey’s post-hoc; p = 0.75). Additionally, when stimulated with srDesAcetyl-αMSH, the esMC3R EC2 chimeric did not cause a significant decrease in
sensitivity with an EC50 value of 4.0 x 10-8 M ± 1.8 x 10-8 M compared to wild-type
wsMC2R (Figure 22C; EC50 = 4.2 x 10-9 M ± 7.5 x 10-10 M; One-way ANOVA/Tukey’s
post-hoc; p = 0.80).

Imaging of Cell Surface Expression of wsMC2R/esMC3R Chimeric
The potential effect of the esMC3R EC3 chimeric on cell surface trafficking was
also observed. Compared to control wsMC2R (Figure 22D; 1.2 ± 0.09 Lumens/pixel), the
chimeric receptor resulted in 1.0 ± 0.05 Lumens/pixel, which was not a significant decrease
in trafficking of the receptor to the plasma membrane (Figure 22E; One-way
ANOVA/Dunnett’s post-hoc; p = 0.36).

Modeling of a wsMC2R/xtMC1R EC1 Chimeric
To begin the analysis of whether the EC1 region of wsMC2R might be the region
of interaction between the N-terminal of wsMRAP1 and an EC region of wsMC2R, a
precursor analysis utilizing the I-TASSER software server (Roy et al. 2010, Yang et al.
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2015, Yang and Zhang 2015, Zhang et al. 2017) was performed. This model was created
in the method previously mentioned, with the EC1 region of the wild type wsMC2R being
replaced by that from the xtMC1R peptide sequence. This model had a C-score of -0.48
and an RMSD-value of 7.4 ± 4.3 Å (Figure 23A), suggesting that this protein would not be
prematurely degraded. The chimeric model was then compared to the WT wsMC2R model
using a VMD analysis of RMSD which determined that the mean difference between the
structures was 17.2 Å. This preliminary virtual analysis suggested productive use of this
chimeric receptor for further biochemical study.

Analysis of Activation of wsMC2R/xtMC1R EC1 Chimeric by ACTH and MSH
When stimulated with srACTH(1-24), the xtMC1R EC1 chimeric caused a
significant 10-fold decrease in sensitivity, with an EC50 value of 2.34 x 10-10 M ± 3.16 x
10-11 M compared to wild-type wsMC2R which had an EC50 value of 4.29 x 10-11 M ± 1.14
x 10-11 M (Figure 23B; One-way ANOVA/Tukey’s post-hoc; p = 0.02). However, no
significant decrease in sensitivity was observed when the xtMC1R EC1 chimeric was
stimulated with srDes-Acetyl-αMSH. The xtMC1R EC1 chimeric had an EC50 value of 8.5
x 10-8 M ± 1.8 x 10-10 M, compared to wild type wsMC2R which had an EC50 value of 4.8
x 10-8 M ± 9.9 x 10-10 M (Figure 23C; One-way ANOVA/Tukey’s post-hoc; p = 0.08).
More striking than the effect of the xtMC1R EC1 chimeric substitution on the EC50
of the wsMC2R was the dramatic decrease in Vmax. This observation suggested that this
specific chimeric may not be directly affecting the sensitivity of the receptor and a
corresponding interaction of wsMRAP1, but rather effecting the amount of receptor
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Figure 23. Analysis of xtMC1R EC1 chimeric modeling, activation and
trafficking A) 3D model of the xtMC1R EC1 chimeric (EC2 region in red). Model
was most closely related to proteins such as the human delta opioid 7TM receptor
(PDB ID: 4n6h) and the human adenosine A1 receptor (PDB ID: 5uen). B)
Stimulation of xtMC1R EC1 chimeric with srACTH(1-24). Data points represented
as mean ± SEM (n = 3). Significance set at p < 0.05. C) Stimulation of xtMC1R EC1
chimeric with srDes-Acetyl-αMSH. Data points represented as mean ± SEM.
Significance set at p < 0.05. D) Immunofluorescent cell-surface imaging of wsMC2R
and xtMC1R EC1 chimeric. Images of non-permeabilized cells. All receptor
constructs were expressed with wsMRAP1. The xtMC1R EC1 chimeric (2nd row)
was expressed at levels significantly decreased compared to control. Images show
maximum z projections. Scale bar = 1μm. E) Analysis of mean fluorescence. Data
sets represented as mean ± SEM (n = 50). Significance set at p < 0.05. Data points
represented as mean ± SEM. Significance set at p < 0.05.
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trafficking to the cell surface, thus indirectly diminishing levels of receptor activation. In
order to test this suspicion, receptor expression at the cell surface was analyzed.

Imaging of Cell Surface Expression of wsMC2R/xtMC1R EC1 Chimeric
Unlike the other EC chimerics previously observed, the xtMC1R EC1 chimeric
caused a significant decrease in cell-surface expression (Figure 23E; t-test; p < 0.0001).
The xtMC1R EC1 chimeric had a mean fluorescence of 0.59 ± 0.10 Lumens/pixel,
compared to wild type wsMC2R which had a mean fluorescence of 1.78 ± 0.13
Lumens/pixel (Figure 23D). This confirmed the suspicions caused by the dramatic
decrease in Vmax caused by this chimeric, suggesting that the significant diminishing of
activation was unlikely to be caused by the alteration of the EC1 region directly

Discussion
Based on previous studies analyzing the region of interaction between hMC2R and
hMRAP1 which found that the location of interaction was likely the EC2 region of hMC2R
(Davis 2018), it was expected that the EC2 region of wsMC2R would also be the region of
interaction for wsMC2R and wsMRAP1. This led to the hypothesis for the present portion
of this study that if the EC2 region of wsMC2R is the site of interaction between wsMC2R
and wsMRAP1, then when this region of wsMC2R is replaced with a corresponding region
from xtMC1R, a receptor which does not interact with MRAP1, receptor function will be
disturbed. However, this hypothesis was not supported by the results. When a chimeric
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receptor was created which replaced the EC2 region of wsMC2R with the corresponding
region from xtMC1R, neither activation was blocked nor was trafficking negatively
affected. This suggested that the EC2 region of wsMC2R is not the site of interaction
between wsMC2R and wsMRAP1.
In an effort to further confirm this observation, a second chimeric was created
which replaced the EC2 region of wsMC2R with the corresponding region of esMC3R, a
cartilaginous fish receptor which does not interact with MRAP1. When this receptor was
analyzed in the same manner, similar results were yielded. The observations of this
chimeric further supported the conclusion that the EC2 region of wsMC2R is not the site
of interaction for wsMC2R and wsMRAP1.
Continuing to look at another EC domain of wsMC2R as the potential extracellular
region of interaction between wsMC2R and wsMRAP1, a chimeric which replaced the
EC1 region of the wsMC2R ortholog with the corresponding region from xtMC1R was
created. For this chimeric, the sensitivity to stimulation with srACTH(1-24) was decreased
10-fold, but there was no decrease in sensitivity to srDes-Acetyl-αMSH. More notable
however, was that the substitution to the EC1 region caused a dramatic decrease in Vmax,
suggesting some effect on the ability for the chimeric to traffic to the cell surface. This
proposition was further supported by analyzing the cell surface expression of the xtMC1R
EC1 chimeric, which was present at significantly lower levels than the wild type wsMC2R.
Together, these results suggest that the xtMC1R chimeric is not having a direct effect on
the ligand sensitivity or activation of wsMC2R, but rather is affecting trafficking. Since
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the extracellular domains do not play a known role in trafficking of wsMC2R, it is unsure
why such a dramatic effect is caused by this specific chimeric.
In previous study of the hMC2R, a similar result for the EC1 chimeric was observed
(Davis 2018). To further identify the potential cause for such diminished receptor function,
cassette alanine mutants were made to observe the effect of smaller portions within EC1.
The results of this study revealed that the cassette closest to TM2 were the most detrimental
to receptor function (Davis 2018). It was proposed that the reason for this effect is that
alteration to this region of EC1 interferes with residues in TM2 which have been known to
be a part of the H6F7R8W9 binding pocket (Chen et al. 2007, Chung et al. 2008). In order
to determine whether the same affect is occurring for the wsMC2R, a similar cassette
approach would be prudent. However, such an experiment exceeds the realm of the
objectives for the present thesis. Taking the results seen for the wsMC2R/xtMC1R EC1 it
is unlikely that the wsMRAP1 N-terminal is interacting with wsMC2R EC1, since this
interaction does not play a role in trafficking, and that is what was affected by the EC1
chimeric. An effect on trafficking suggests instead some perturbation to the transmembrane
contact.
These experiments overall did not support the hypothesis that an interaction
between the N-terminal of wsMRAP1 and an extracellular domain of wsMC2R is
necessary for receptor function. Substitution of the EC2 domain had no effect on sensitivity
to ligand following stimulation with either srACTH(1-24) or srDes-Acetyl-αMSH. This is
in addition to the chimeric receptor experiments presented on Chapter 4 indicate that
neither the N-terminal domain nor the EC3 domain appear to be the contact sites for the N65

terminal of wsMRAP1. While the EC1 chimeric caused a decrease in sensitivity to
srACTH(1-24), there was no decrease in sensitivity to srDes-Acetyl-αMSH , and the EC1
chimeric primarily showed a perturbation to trafficking which suggests indirect effect
rather than direct necessity of EC1 for a wsMRAP1/wsMC2R interaction. Taken together
this suggests that there may not be a necessary interaction between an extracellular region
of wsMC2R and the N-terminal of wsMRAP1 for activation of the wsMC2R ortholog. This
is contradictory to the results seen in similar studies of the bony vertebrate MC2R orthologs
which require this interaction for functional activation (Sebag and Hinkle 2009, Malik et
al. 2015).
This observation poses a question about the functioning of the wsMC2R and the
role of the wsMRAP1. The proposed activation motif within the peptide sequence of
MRAP1 is within the N-terminal (Sebag and Hinkle 2009). Thus, the results from this
study inquire whether the activation motif is not fundamental for functional activation of
the wsMC2R ortholog, or even further, if the wsMRAP1 homolog has an activation motif
at all. Either situation would be in stark contrast to the understood relationship of bony
vertebrate MC2R orthologs and their respective MRAP1 paralogs, and future investigation
of this question could more thoroughly reveal the question of this potential evolutionary
divergence. If either reality is the case, then taking the understanding from previous
characterization of wsMC2R, that wsMRAP1 is necessary for optimal function (Chapter
2), investigation continues to locate the region of interaction between wsMRAP1 and
wsMC2R. Since the mode of assistance remaining would be that of trafficking, attentions
were focused to the transmembrane contact site between these proteins.
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CHAPTER 6: INVESTIGATION OF THE TRANSMEMBRANE SITE OF CONTACT
FOR WHALE SHARK MC2R AND WHALE SHARK MRAP1

Part One: Extension of Region of Interest to Include TM4 or TM5

Modeling of a wsMC2R/wsMRAP1 Dimer
Since the studies utilizing a chimeric receptor approach of the extracellular regions
of the wsMC2R ortholog indicated that there is not an interaction occurring between an
extracellular domain of wsMC2R and the N-terminus of wsMRAP1, another potential
region for the interaction between wsMC2R and wsMRAP1 needed to be located. In
addition to the interaction between bony vertebrate MC2R and MRAP1 on the extracellular
side which is understood to play a role in receptor activation, the transmembrane region of
MRAP1 is also understood to interact with a TM region within MC2R to assist in receptor
trafficking to the cell surface (Dores et al. 2016).

Previous studies on the

hMC2R/hMRAP1 interaction implicated that in addition to the interaction of the hMRAP1
N-terminal and the hMC2R EC2, there was evidence showing additional important
residues in the TM4 and TM5 regions of hMC2R as well (Davis 2018). This suggested that
for localizing the wsMC2R/wsMRAP1 region of interaction, attention should be turned to
a transmembrane domain. The presenting challenge, however, was that since none of the
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extracellular regions appeared to be the region of interaction, for the N-terminal of
wsMRAP1, which TM domain to address initially was at first unclear. Thus a unique
approach was taken to determine the initial region of focus.
Utilizing the Shrödinger BioLuminate software server (Schrödinger, LLC), a
protein-protein docking simulation was run to identify a potential site of interaction
between the wsMC2R and wsMRAP1. This simulation utilized the wsMC2R and
wsMRAP1 3D models previously discussed. Using the models, the software analyzed
potential conformations based on protein structure and amino acid residue interactions. The
simulation was set to analyze 70,000 potential conformations and output the 30
conformations which were most energetically favorable, which can be seen in Figure 24.
The outputs were then analyzed manually by appearance to find a potential region of focus
to start biochemical analyses.
Of the 30 output structures, seven structures could be eliminated as possible
suggestions since the structural conformation did not represent something physiologically
possible in the presence of a lipid bilayer, which this structure would inhabit in an actual
cell environment. From the remaining structures, 18 had the location of interaction in the
TM4-EC2-TM5 region (78%), one had the location of interaction in the TM2-EC1-TM3
region (4%), and four had the location of interaction in the EC3-TM6/TM1 region (17%).
It was decided that since the simulation suggested the TM4-EC2-TM5 region as most likely
for the location of interaction, this region would be the first focus for further studies

68

A

wsMRAP1
N-terminal

B

wsMC2R
N-terminal

wsMC2R
TM5

wsMRAP1
C-terminus

Figure 24. Top 30 outputs from protein docking simulation. The Schrödinger
BioLuminate software (Schrödinger, LLC) simulation determined these as the
most energetically favorable from 70,000 potential interactions analyzed. A)
Outlines used to group outputs into categories used for analysis; (blue): models
which suggest TM4-EC2-TM5 as contact region, (red): models that suggest EC3TM6/TM1 as contact region, (yellow): model that suggested TM2-EC1-TM3 as
contact region, (purple); models excluded due to non-physiological compatibility
with a lipid bilayer. B) Zoomed-in version of one of the outputs. wsMC2R in
green, wsMRAP1 in cyan.
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Modeling of wsMC2R/xtMC1R TM4-EC2-TM5 Region Chimerics
To begin the study of this new region of focus, chimeric receptors which altered a
larger region of potential interaction were developed to include either TM4 or TM5 of
wsMC2R. Using the corresponding regions from xtMC1R, chimerics which replaced
either the TM4-EC2 or EC2-TM5 region altogether were created. In order to preemptively
analyze whether these chimerics had the potential for being functional, three-dimensional
models of these two chimeric receptors were developed utilizing the I-TASSER software
server (Roy et al. 2010, Yang et al. 2015, Yang and Zhang 2015, Zhang et al. 2017). The
xtMC1R TM4-EC2 chimeric (Figure 25A) had a C-score of -1.47 and an RMSD value of
9.8 ± 4.6 Å. Compared to wild type wsMC2R, this model had a relatively small RMSD of
11.38 Å according to the VMD analysis. Taken together with the observation that the
identified structures in the Protein Data Bank that were most closely similar to the
developed structure were all rhodopsin type-A GPCRs which also overlapped with those
closely related to the wild type wsMC2R, this structure appeared promising for use in
further biochemical analyses.
The model for the xtMC1R EC2-TM5 chimeric (Figure 25D) had a C-score of 1.50 and an RMSD value of 9.8 ± 4.6 Å. Compared to wild-type wsMC2R, this model had
a mean difference of only 10.24 Å and related closely to known structures similar to those
which related to wild-type wsMC2R. This combined with the utilization of similar
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Figure 25. Analysis of modeling and activation of xtMC1R TM4-EC2 chimeric
and xtMC1R EC2-TM5 chimeric. A) Model of xtMC1R TM4-EC2 chimeric
receptor. TM4 in pink and EC2 in yellow. Model was most closely related to proteins
such as the human melatonin receptor 6me6 (PDB ID: 6me6), the human B2adrenergic GPCR (PDB ID: 2rh1), and the human MC4R (PDB ID: 6w25). B)
xtMC1R TM4-EC2 chimeric stimulated with srACTH(1-24). Data points represented
as mean ± SEM (n = 3). Significance set at p < 0.05. C) xtMC1R EC2-TM5 chimeric
stimulated with srDes-Acetyl-αMSH. Data points represented as mean ± SEM (n =
3). Significance set at p < 0.05. D) Model of xtMC1R EC2-TM5. EC2 in yellow
and TM5 in green. Model was most closely related to proteins such as the human
CB1 cannabinoid receptor (PDB ID: 5tjv), the human M4 muscarine receptor (6kp6)
and the human MC4R (PDB ID: 6w25). E) xtMC21R EC2-TM5 chimeric stimulated
with srACTH(1-24). Data points represented as mean ± SEM (n = 3). Significance
set at p < 0.05. F) xtMC1R EC2-TM5 chimeric stimulated with srDes-Acetyl-αMSH.
Data points represented as mean ± SEM (n = 3). Significance set at p < 0.05.
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threading templates, it seemed likely that this chimeric would also be useful for further
biochemical analyses.

Analysis of Activation of TM4-EC2-TM5 Region Chimerics by ACTH and MSH
Based on the initial modeling simulations and previous studies characterizing the
hMC2R-hMRAP1 interaction (Davis 2018), attention was focused on the TM4-EC2-TM5
region of the wsMC2R ortholog as the likely interaction site for wsMC2R and wsMRAP1.
To approach this question, chimeric receptors were created which replaced either the TM4EC2 region or EC2-TM5 region of wsMC2R with the corresponding region from xtMC1R.
These chimerics were created in an attempt to perturb the normal interaction with
wsMRAP1, since the xtMC1R is not dependent on an MRAP1 ortholog for activation or
trafficking, in order to isolate the region of interaction between wsMC2R and wsMRAP1.
For the TM4-EC2 chimeric, there was not a significant difference in activation by
srACTH(1-24) between the chimeric (Figure 25B; EC50 = 2.0 x 10-9 M ± 6.6 x 10-10 M;
One-way ANOVA/Tukey’s post-hoc; p = 0.88) and the wild-type wsMC2R (EC50 = 6.8 x
10-10 M ± 4.6 x 10-11 M). There was also no significant difference in activation between
the TM4-EC2 chimeric (stimulation only at peptide concentration of 1 x 10-6 M) and wildtype wsMC2R (EC50 = 6.4 x 10-9 M ± 7.6 x 10-9 M) when stimulated with srDes-AcetylαMSH (Figure 25C); One-way ANOVA/Tukey’s post-hoc; p = 0.56). These results
suggested that the TM4 region of wsMC2R was not likely to be the site of interaction for
wsMRAP1. The EC2-TM5 chimeric receptor however completely diminished receptor

72

activation with srACTH(1-24) (Figure 25E) and srDes-Acetyl-αMSH (Figure 25F). This
strongly suggested TM5 as the likely interaction site for wsMRAP1.

Imaging of Cell Surface Expression of TM4-EC2-TM5 Region Chimerics
To further investigate the role of the TM4 compared to TM5 as the potential region
for interaction of wsMC2R with wsMRAP1, analysis of the cell-surface expression of each
chimeric was compared. Compared to control wsMC2R (1.2 ± 0.09 Lumens/pixel) the
TM4-EC2 chimeric had a mean fluorescence of 1.4 ± 0.08 Lumens/pixel which was not
significantly different (Figure 26; One-way ANOVA/Dunnett’s post-hoc; p = 0.11).
However, the EC2-TM5 chimeric had a mean fluorescence of 0.42 ± 0.04 Lumens/pixel
which was significantly decreased compared to control (Figure 26; One-way
ANOVA/Dunnett’s post-hoc; p < 0.0001). Combined with the decrease in activation, the
decreased cell-surface expression of the EC2-TM5 mutant points toward this region as the
likely point of interaction for wsMRAP1 with wsMC2R, since wsMRAP1 is necessary for
optimal trafficking and activation of wsMC2R.
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Figure 26. Immunofluorescent cell-surface imaging of xtMC1R TM4-EC2 and
EC2-TM5 chimerics. A) Cell-surface imaging of wsMC2R, xtMC1R TM4-EC2
chimeric and xtMC1R EC2-TM5 chimerics. Images of non-permeabilized cells. All
receptor constructs were expressed with wsMRAP1. The xtMC1R TM4-EC2
chimeric (2nd row) was expressed at levels not significantly different from control.
The xtMC1R EC2-TM5- chimeric was expressed at significantly lower levels than
control wsMC2R. Images show maximum z projections. Scale bar = 1μm. B)
Analysis of mean fluorescence. Data sets represented as mean ± SEM (n = 50).
Significance set at p < 0.05.
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Discussion
Expanding the region of focus for a potential region to include EC2 as well as either
TM4 or TM5 was attempted in order to identify the location for interaction between
wsMC2R and wsMRAP1. Since previous studies on the site of interaction between
hMC2R and hMRAP1 implicated the general region of TM4-EC2-TM5 as the location for
interaction (Davis 2018), and protein-protein docking simulations supported this previous
observation, the corresponding region of the wsMC2R ortholog was made the focus. The
operating hypothesis for the present section of this study was that if the site of interaction
was either TM4 or TM5, then when this region of the wsMC2R ortholog was replaced with
the corresponding region of xtMC1R, a receptor which does not interact with MRAP1, then
receptor function would be disturbed.
In activation studies, replacing the TM4-EC2 region of wsMC2R with the
corresponding region from xtMC1R did not have a large effect on stimulation by either
srACTH(1-24) or srDes-Acetyl-αMSH. The TM4-EC2 chimeric similarly did not have a
significant effect on receptor trafficking. However, replacement of the wsMC2R EC2TM5 region with the corresponding residues from xtMC1R completely diminished
activation when stimulated by either srACTH(1-24) or srDes-Acetyl-αMSH. Additionally,
the xtMC1R EC2-TM5 chimeric significantly disrupted trafficking to the cell surface.
These results suggest that for wsMC2R, the region of interaction with wsMRAP1
is located within TM5. This observation is in support of the operating hypothesis, which
implicated that if wsMRAP1 was interacting with a TM region of wsMC2R, then when
this region was replaced with the corresponding region from xtMC1R, receptor function
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would be disrupted. This suggests that for the wsMC2R ortholog, an interaction between
the transmembrane region of wsMRAP1 is valuable for optimal functioning. In order to
further isolate the specific residues which are necessary for interaction between wsMC2R
and wsMRAP1, focus was narrowed to TM5 specifically.

Part Two: Narrowing Focus of Region to Individual Residues
Determination of TM5 Region of Interest for Potential wsMRAP1 Contact Site
Based on the chimeric studies previously described, more detailed attention was
focused on the TM5 region of wsMC2R as the likely locus of interaction for wsMRAP1.
The operating hypothesis for this portion of the study was that if the key residues for
interaction between wsMC2R and wsMRAP1 were mutated, then the function of wsMC2R
would be disrupted. In order to isolate the most probable region in which wsMRAP1
interacts with the TM5 of wsMRAP1, the wsMC2R region was aligned with other MC2R
orthologs (esMC2R, srMC2R, hMC2R; Figure 27A) to analyze regions of homology. The
alignments revealed that the region of TM5 which was closer to the extracellular side of
the protein displayed much less similarity among orthologs, so single alanine mutants were
made to the residues in this region to pinpoint the amino acids involved in the wsMC2RwsMRAP1 interaction.

Analysis of Activation of wsMC2R TM5 Single-alanine Mutants by ACTH and MSH
Initial look at the activation of the single-alanine mutants developed a somewhat
confusing picture, to be discussed further after initial reporting of the results. The first set
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of single-alanine mutants addressed the residues S204, F205, F206, and F207 (Figure 27B,
27C). When the mutants were stimulated with srACTH(1-24) the S204A, F206A and
F207A mutants all caused significant decreases in ligand sensitivity compared to control
wsMC2R (Table 1). The F205A mutant did not cause a significant decrease in sensitivity.
When stimulated with srDes-Acetyl-αMSH, only the F206A mutant had an effect,
completely diminishing activation, but the other mutants had no effect on ligand sensitivity.
The second set of single alanine mutants addressed the subsequent four residues:
V208, L209, F210 and F211 (Figure 27D, 27E). When the mutants were stimulated with
srACTH(1-24), neither the V208A mutant nor the L209A mutant decreased activation.
However, both the F210A and F211A mutants both caused significant decreases in
activation compared to control. When stimulated with srDes-Acetyl-αMSH, none of the
second set of single-alanine mutants significantly disrupted activation.
What made a firm conclusion based on these observations difficult is that when
looking at the sensitivity curves (Figure 27); all of the lines appear to be very close together.
Due to small margins of error, the ANOVA analysis suggested significance for the amount
of decrease for some mutants, but when the fold-shift of the actual EC50 values is compared
to the wild-type wsMC2R, the difference is in the range which can be attributed to noise in
the assay. Similarly, a larger fold-shift did not correspond with a significant difference in
sensitivity with the F207A mutants, suggesting that another form of analysis would be
necessary to understand the effect that these mutants were truly having on the function of
the wsMC2R. taking another look at the activation curves, the most notable trait is that
while the lines are close together at the EC50 value, the height of the curves are dramatically
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Figure 27. TM5 single-alanine mutants A) Peptide sequence alignment of TM4EC2-TM region for wsMC2R (XM_020525249.1), esMC2R (FAA704.1),
srMC2R (LC108747) and hMC2R (AAI04170.1). Residues identical among
cartilaginous fish orthologs represented in blue; residues identical among all
orthologs represented in red. Motif within green brackets is the SFFF, VLFF motifs
to be focused on with the single-alanine mutants. B) wsMC2R single-alanine
mutants: S204A, F205A, F206A and F207A stimulated with srACTH(1-24). Data
points represented as mean ± SEM (n = 3). Significance set at p < 0.05. C)
wsMC2R single-alanine mutants: S204A, F205A, F206A and F207A stimulated
with srDes-Acetyl-αMSH. Data points represented as mean ± SEM (n = 3).
Significance set at p < 0.05. D) wsMC2R single-alanine mutants: V208A, L209A,
F210A, F211A stimulated with srACTH(1-24). Data points represented as mean
± SEM (n = 3). Significance set at p < 0.05. E). wsMC2R single-alanine mutants:
V208A, L209A, F210A, F211A stimulated with srDes-Acetyl-αMSH. Data points
represented as mean ± SEM (n = 3). Significance set at p < 0.05.
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srACTH(1-24)
srDes-Acetyl-αMSH
srACTH(1-24)
srDes-Acetyl-αMSH

Mutant

EC50 value

P-value (One-way ANOVA)

Fold-shift

wsMC2R1

7.9 x 10-12 M ± 3.1 x 10-12 M

--

--

S204A

5.7 x 10-12 M ± 1.8 x 10-12 M

p = 0.006

1.38

F205A

5.3 x 10-12 M ± 1.9 x 10-12 M

p = 0.07

1.49

F206A

1.3 x 10-11 M ± 4.7 x 10-12 M

p < 0.0001

0.06

F207A

7.8 x 10-12 M ± 6.4 x 10-12 M

p < 0.0001

1.01

wsMC2R2

4.5 x 10-10 M ± 5.2 x 10-10 M

--

--

S204A

3.6 x 10-10 M ± 8.5 x 10-10 M

p = 0.99

1.25

F205A

1.6 x 10-10 M ± 3.7 x 10-10 M

p = 0.98

2.82

F206A

No stimulation

--

--

F207A

3.4 x 10-12 M ± 9.7 x 10-12 M

p = 0.99

132.35

wsMC2R3

2.0 x 10-11 M ± 5.7 x 10-12 M

--

--

V208A

2.4 x 10-11 M ± 1.4 x 10-11 M

p = 0.75

0.83

L209A

1.9 x 10-11 M ± 9.3 x 10-12 M

p = 0.97

1.05

-11

F210A

9.3 x 10

M

p = 0.006

4.65

F211A

2.2 x 10-11 M ± 1.9 x 10-11 M

p = 0.006

0.91

wsMC2R4

5.7 x10 -8 M ± 2.5 x 10-8 M

--

--

-8

M ± 5.8 x 10

-11

-9

V208A

1.2 x10

M ± 2.6 x 10 M

0.99

4.75

L209A

1.2 x10 -8 M ± 4.0 x 10-9 M

0.22

4.75

F210A

5.0 x10 -8 M ± 2.2 x 10-8 M

0.05

1.14

F211A

7.5 x10 -9 M ± 1.9 x 10-9 M

0.29

7.6

Table 1. EC50 value analysis of TM single-alanine mutants. Listed EC50 values
along with the calculated P-values from ANOVA analysis as well as the fold-shift
difference between the wild-type receptor EC50 and the mutant EC50. Superscripted
denotations on wsMC2R indicate separate wild-type controls from separate assays.
All assays were performed in triplicate. EC50 values are represented at mean ±
SEM. Significance is set at p < 0.05.
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different. This suggests the possibility for another effect of these single alanine mutants,
but a detailed comparison of Vmax values would be necessary.

Analysis of Vmax for wsMC2R TM5-Single-alanine Mutants
In order to thoroughly determine the effect of these individual substitutions, another
metric was analyzed. The Vmax value for each mutant was compared, which reflects a
comparison of the relative number of receptors at the cell surface; Vmax is the peptide
concentration at which the receptors reach saturation. Looking at the first set of mutants
(SFFF), all four of these mutants had a significantly decreased Vmax value compared to
wild type wsMC2R when stimulated with srACTH(1-24). The S204A mutant had a Vmax
of 23038 ± 853.8 Relative Light Units (RLU) compared to wild type wsMC2R which had
a Vmax of 52624 ± 2502.1 RLU (Figure 28A; One-way ANOVA/Dunnett’s post-hoc; p <
0.0001). The F205A and F206A mutants had Vmax values of 30407 ± 1242.8 RLU and 8023
± 348.6 RLU, respectively (Figure 27A; One-way ANOVA/Dunnett’s post-hoc; p <
0.0001, p < 0.0001). Finally, the F207A mutant had a Vmax of 7184.1 ± 711.47 RLU (Figure
28A; One-way ANOVA/Dunnett’s post-hoc; p < 0.0001).
Looking at the same cassette region stimulated with srDes-Acetyl-αMSH, a nearly
identical pattern emerged. The S204A mutant had a Vmax value of 4311.2 ± 1260.3 RLU
compared to wild type wsMC2R (Vmax = 33436 ± 5510.2 RLU; One-way
ANOVA/Dunnett’s post-hoc; p < 0.0001). The F205A and F207A mutants had Vmax values
of 3968 ± 1299 RLU and 3715.1 ± 1181.8 RLU respectively (Figure 28B; One-way
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ANOVA/Dunnett’s post-hoc; p < 0.0001, p < 0.0001). The F206A mutant had completely
diminished stimulation.
With the second cassette of single-alanine mutants, when stimulated with
srACTH(1-24), the V208A and L209A mutants had Vmax values of 27795 ± 2034.2 RLU
and 31733 ± 1894.6 RLU compared to wild-type wsMC2R (36886 ± 1243.4 RLU; Figure
27C; One-way ANOVA/Dunnett’s post-hoc; p = 0.01, p = 0.29). The F210A and F211A
both had significant decreases in Vmax compared to wild type wsMC2R, with Vmax values
of 9900.9 ± 849.5 RLU and 9231.4 ± 966.43 RLU respectively (Figure 28C; One-way
ANOVA/Dunnett’s post-hoc; p < 0.0001, p < 0.0001).
For the same cassette of single-alanine mutants stimulated with srDes-AcetylαMSH, a less dramatic effect was seen. Neither the V208A nor the L209A mutant caused
a significant decrease in Vmax compared to wild type wsMC2R. The V208A mutant had a
Vmax value of 20834 ± 875.96 RLU and the L209A mutant had a Vmax value of 14651 ±
14651 ± 947.8 RLU, compared to wild type wsMC2R (18728 ± 1917.3 RLU; Figure 28D;
One-way ANOVA/Dunnett’s post-hoc; p = 0.12, p = 0.83). Similarly, neither the F210A
nor the F211A mutants caused a significant decrease (Figure 28D; One-way
ANOVA/Dunnett’s post-hoc; p = 0.84, p < 0.0001). The F210A mutant had a Vmax value
of 19783 ± 2017.7 RLU, and the F211A mutant had a Vmax value (Vmax = 40239 ± 1905.3
RLU) higher than that for wild type wsMC2R.
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Figure 28. Vmax values for wsMC2R TM5 single-alanine mutants
stimulated with srACTH(1-24) and srDes-Acetyl-αMSH. Data points
represented as mean ± SEM (n = 3)of Vmax values from where receptor
reached saturation. A) First set wsMC2R TM5 chimerics (S204AF207A) stimulated with srACTH(1-24). B) A) First set wsMC2R TM5
chimerics (S204A-F207A) stimulated with srDes-Acetyl-αMSH. C)
Second set wsMC2R TM5 chimerics (V208A-F211A) stimulated with
srACTH(1-24). D) Second set wsMC2R TM5 chimerics (V208AF211A) stimulated with srDes-Acetyl-αMSH.
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Imaging of Cell Surface Expression of wsMC2R TM5 Single-alanine Mutants
In further addressing the role of these individual amino acid residues in TM5 for
their impact on the interaction between wsMC2R and wsMRAP1, the effect on cell-surface
trafficking was observed. For the first set of single-alanine mutants (SFFF), compared to
control wsMC2R which showed cell-surface expression at a mean 1.54 ± 0.10
Lumens/pixel, all mutants led to a decrease in cell-surface expression (Figure 29). The
S204A mutant had a mean fluorescence of 1.19 ± 0.10 Lumens/pixel, a significant decrease
compared to control (One-way ANOVA/Dunnett’s post-hoc; p = 0.03). The F205A and
F206A mutants expressed at mean fluorescence of 1.09 ± 0.23 Lumens/pixel and 1.17 ±
0.07 Lumens/pixel respectively, both significantly less than control (One-way
ANOVA/Dunnett’s post-hoc; p = 0.003, p = 0.02). The F207A mutant, while less
expressed than control was not a significant decrease at a mean fluorescence of 1.4 ± 0.12
Lumens/pixel (One-way ANOVA/Dunnett’s post-hoc; p = 0.66). For the second set of
single-alanine mutants, both the V208A and L209A mutants showed a significantly
decreased mean fluorescence compared to control wsMC2R (4.17 ± 0.28 Lumens/pixel),
expressing at mean fluorescence of 2.95 ± 0.26 Lumens/pixel and 2.74 ± 0.27
Lumens/pixel respectively (Figure 30; One-way ANOVA/Dunnett’s post-hoc; p = 0.005,
p < 0.001). The F210A and F211A mutants did not significantly decrease cell-surface
expression with mean fluorescent values of 3.56 ± 0.26 Lumens/pixel and 3.07 ± 0.23
Lumens/pixel respectively (Figure 30; One-way ANOVA/Dunnett’s post-hoc; p = 0.29, p
= 0.29).
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Figure 29. Immunofluorescent cell-surface imaging of SFFF singlealanine mutants. A) Cell-surface imaging of wsMC2R SFFF single-alanine
mutants. Images of non-permeabilized cells. All receptor constructs were
expressed with wsMRAP1. The S204A, F205A and F206A were all
expressed at a significantly lower level than wild type wsMC2R. The F207A
construct was only expressed at a slightly lower level than wild type
wsMC2R. Images show maximum z projections. Scale bar = 1μm. B)
Zoomed-in model of wsMC2R with residues of interest (S204A, F205A,
F206A, F207A) labeled in red. C) Analysis of mean fluorescence. Data sets
represented as mean ± SEM (n = 50). Significance set at p < 0.05.
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Discussion
Since the chimeric receptor which replaced the TM5 region of the wsMC2R
ortholog with the corresponding region of xtMC1R led to a dramatic reduction in receptor
function, a more specific investigation of wsMC2R TM5 was prudent. This was in order
to determine the specific residues involved in the site of interaction for wsMC2R and
wsMRAP1. Initial alignment of the TM5 region of multiple MC2R orthologs revealed that
the residues within TM5 which were closest to the EC2 represented more variability, and
therefore were most likely the region of interaction. Single-alanine mutants which replaced
individual residues within this region of TM5 were created to analyze the importance of
each of these residues for the interaction between wsMC2R and wsMRAP1. The operating
hypothesis for this section of the present thesis was that if the key residues for interaction
between wsMC2R and wsMRAP1 were mutated, then the function of wsMC2R would be
disturbed.
Within the first cassette of single-alanine mutants (SFFF region), the S204A,
F206A and F207A mutants all caused a decrease in sensitivity to srACTH(1-24). Only
the F206A mutant however affected sensitivity to srDes-Acetyl-αMSH. The F205A
mutant did not have an effect on receptor stimulation with either peptide. Looking at the
second cassette of single-alanine mutants (VLFF region), both the F210A mutant and the
F211A mutant caused a large decrease in sensitivity to srACTH(1-24). The F210 mutant
was the only mutant in the second cassette which caused a significant decrease in
sensitivity to srDes-Acetyl-αMSH. The V208A and L209A peptides did not cause an effect
to stimulation with either peptide. Taken together, the results from the activation studies
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Figure 30. Immunofluorescent cell-surface imaging of VLFF single-alanine
mutants. A) Cell-surface imaging of wsMC2R VLFF single-alanine mutants.
Images of non-permeabilized cells. All receptor constructs were expressed with
wsMRAP1. The V208A and L209A mutants were both expressed at a significantly
lower level compared to wild type wsMC2R. The F210A and F211A mutants were
not expressed at a level significantly less than wild type wsMC2R. Images show
maximum z projections. Scale bar = 1μm. B) Zoomed-in model of wsMC2R with
residues of interest (V208A, L209A, F210A, F211A) labeled in red. C) Analysis
of mean fluorescence. Data sets represented as mean ± SEM (n = 50). Significance
set at p < 0.05.
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present a mosaic picture. While the significant differences in EC50 values was
pharmacologically relevant, the differences were not large enough to be physiologically
relevant. Thus, this inspired analysis of the sensitivity curves utilizing another metric, and
a comparison of the Vmax values was completed ( Vmax representing the point of receptor
saturation).
Analysis of the first set of single-alanine mutants revealed that all mutants caused
a significant decrease in Vmax, regardless of stimulation with either srACTH(1-24) or
srDes-Acetyl-αMSH (Table 2). For the second set of mutants, the F210A mutant caused a
significant decrease in Vmax for stimulation with either srACTH(1-24) or srDes-AcetylαMSH. The V208A and L209A mutants only caused a decrease in Vmax for stimulation
with srDes-Acetyl-αMSH and the F211A mutant only caused a significant decrease for
stimulation with srACTH(1-24) (Table 2). Looking at the Vmax analysis as a whole, the
results suggest that these single-alanine mutants are disrupting the function of wsMC2R by
disturbing the interaction between wsMC2R and wsMRAP1 which allows for optimal
trafficking of wsMC2R to the cell membrane. Despite an unaltered sensitivity to ligand,
these mutations disrupt the interaction enough to decrease the number of receptors which
are able to access ligand. Taken together, these considerations of the activation assays
suggest that the main consequence of these mutants is not a decrease in ligand sensitivity,
but rather an effect on trafficking, which diminishes the number of receptors at the cell
surface and indirectly decreasing the level of activation. In order to further support this
idea, imaging of cell surface expression was also performed.
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Vmax srDes-Acetyl-αMSH
Mutant

wsMC2R

Vmax srACTH(1-24) (RLU)
1

P-value

(RLU)

Mean Fluorescence
P-value

(Lumens/pixel)

P-value

52624 ± 2502.1

--

33436 ± 5510.2

--

1.54 ± 0.10

--

S204A

23038 ± 853.8

< 0.0001

4311.2 ± 1260.3

< 0.0001

1.19 ± 0.10

0.03

F205A

30407 ± 1242.8

< 0.0001

3968 ± 1299

< 0.0001

1.09 ± 0.23

0.003

F206A

8023 ± 348.6

< 0.0001

No stimulation

--

1.17 ± 0.07

0.02

F207A

7184.1 ± 711.47

< 0.0001

3715.1 ± 1181.8

< 0.0001

1.4 ± 0.12

0.66

wsMC2R2

36886 ± 1243.4

--

18728 ± 1917.3

--

4.17 ± 0.28

--

V208A

27795 ± 2034.2

0.01

20834 ± 875.96

0.12

2.95 ± 0.26

0.005

L209A

31733 ± 1894.6

0.29

14651 ± 947.8

0.83

2.74 ± 0.27

0.001

F210A

9900.9 ± 849.5

< 0.0001

19783 ± 2017.7

0.84

3.56 ± 0.26

0.29

F211A

9231.4 ± 966.43

< 0.0001

40239 ± 1905.3

< 0.0001

3.07 ± 0.23

0.29

Table 2. Summary of effect of TM5 single-alanine mutants on cell-surface
expression. Superscripted denotations on wsMC2R indicate separate wild-type
controls from separate assays. All assays were performed in triplicate. Vmax and
mean fluorescence values are represented at mean ± SEM (n = 3; n = 50,
respectively). Significance is set at p < 0.05. Based on these observations, the first
cassette of single-alanine mutants appears to be more likely as the important
residues for contact between wsMRAP1 and wsMC2R. The second cassette of
mutants do not show as clear of a correlation. One possibility for this result is the
interference with a leucine zipper which the L209 residue may participate in,
although further analysis would need to be done to confirm this. The individual
residues which appear to have the highest impact on functioning overall are: S204,
F205, F206, F207, and F211. The importance of phenylalanine residues in the
MC2R/MRAP1 interaction is consistent with results from previous studies.
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Immunofluorescent cell-surface imaging of the mutant receptors allowed for
thorough analysis of the region of interaction between wsMC2R and wsMRAP1. This was
to further analyze their effect on the ability for wsMRAP1 to assist in trafficking wsMC2R
to the cell surface. From the imaging of these cells, it was observed that within the SFFF
motif, the S204A, F205A and F206A mutants all caused a decrease in receptor cell-surface
expression. In the VLFF motif, all mutants decreased cell-surface expression.
Altogether, the results on cell-surface expression combine strongly with the
analysis of the activation assays, providing a clearer picture into the interaction between
wsMC2R and wsMRAP1. From the results of this section it appears that the role of
wsMRAP1 is primarily, if not exclusively trafficking of wsMC2R to the plasma membrane.
As indication from the analysis on Vmax, the region of TM5 closest to the extracellular side
of wsMC2R (SFFF) appears to be the most necessary for optimal function of wsMC2R,
ultimately proposing these residues as the likely region of interaction between wsMC2R
and wsMRAP1.
The results of this portion of the study supported the operating hypothesis which
predicted that when the key residues for interaction between wsMC2R and wsMRAP1
were individually mutated, receptor function would be significantly decreased. These
observations are also consistent with previous studies on the hMC2R/hMRAP1 interaction
which implicated a phenylalanine residue in TM5 of hMC2R as contributing to the ability
for hMRAP1 to assist in functioning of hMC2R (Davis 2018). Similar phenylalanine
residues are likely key for the interaction between the transmembrane region of wsMRAP1
and the wsMC2R ortholog, which is a paramount interaction for trafficking of wsMC2R to
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the cell surface. Therefore, disruption of these residues would decrease the ability of the
wsMC2R ortholog to reach the cell surface, not only limiting cell-surface expression but
also interaction with available ligand leading to subsequent receptor activation.
Further in-depth studies of other orthologs may reveal that the residues which
negotiate the interaction between MC2R and MRAP1 are fully present in the bony
vertebrates, partially present in the wsMC2R ortholog, and potentially absent in the
esMC2R ortholog; this could provide a potential explanation for the array of traits among
the extant bony vertebrate MC2R orthologs, particularly in their interaction with MRAP1.
A full picture of all species would allow for determination of whether these residues
contribute to a trait which was gained in later extant species, and whether that trait is the
loss or the gain of these residues which result in MRAP1 dependence.
Finally, future studies may be able to fully reveal the nature of the relationship of
wsMC2R with wsMRAP1. While in bony vertebrates it has been suggested that the Nterminal of MRAP1 plays a role in the activation of MRAP1, this does not appear to be the
case for the wsMC2R. Mutation to the wsMRAP1 would allow for the building of a
comprehensive picture of these proteins’ interaction, in combination with the data
presented in the present thesis.
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CHAPTER 7: SUMMARY AND CONCLUSIONS

The present thesis began by pursuing whether the wsMC2R would make a good
model for studying the MC2R of cartilaginous fish in more detail.

Initial analysis

supported the wsMC2R as a very good model for study simply on account of all necessary
peptide sequences being completely present and annotated within the genome. Support for
assuming the annotated wsMC2R as such was gained through careful comparison of the
wsMC2R sequence with the sequences of the MC2R orthologs of other cartilaginous fish,
namely the elephant shark and red stingray. Comparison was further pursued by the
modeling of the wsMC2R and subsequent analyses of this model with models of the other
cartilaginous fish MC2Rs. Altogether, this series of comparisons revealed consistency in
sequence and only minor differences in predicted 3D structure (Figures 8-12). Excitingly,
this provided a model system to study the differences within the phylogenetic branches of
Chondrichthyes, as the whale shark is an elasmobranch in addition to the red stingray which
has been studied previously.

Phylogenetic Implications from the Present Study
Characterization of the wsMC2R pharmacology and overall relationship with
MRAP1 revealed that the wsMC2R, independent of wsMRAP1, was only able to be
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stimulated at pharmacologically relevant concentrations of peptide (Figure 14). This
characterization is very similar to what had been seen previously for the other
elasmobranch MC2R ortholog studied, srMC2R (Dores et al. 2018). Neither elasmobranch
MC2R ortholog is physiologically functional when expressed without wsMRAP1. The
unique difference seen in characteristics between the elasmobranch MC2R orthologs
however is that co-expression of wsMRAP2 significantly improves trafficking of
wsMC2R, which is an observation not seen for the srMC2R ortholog.
The traits seen for the elasmobranch MC2R orthologs differ distinctly from the
holocephalan esMC2R ortholog, which is physiologically functional independent of
esMRAP1. This posed an interesting theory about the evolution of these orthologs. It had
previously been assumed that the condition of the esMC2R ortholog, independence from
MRAP1 and ability to be activated by either ACTH or the MSH-sized peptides, was the
ancestral condition for vertebrate MC2Rs. However, the elucidation of the elasmobranch
situation in more detail emphasizes that there is very clear divergence in MC2R
pharmacology between the elasmobranch and holocephalan MC2Rs. This suggests the
possibility that the pharmacological situation seen for the wsMC2R, where MRAP1 is not
absolutely necessary but essentially ‘rescues’ functionality of the receptor, may actually be
closer to the ancestral condition for gnathostome MC2Rs. This would implicate that the
traits of the esMC2R represent a branch of divergent character from this ancestral condition
This theory was further supported by the characterization of the wsMC2R
activation mechanism which more closely resembles the two-step activation mechanism
such as what is seen for bony vertebrate MC2Rs (Figure 17). The phylogenetic implication
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of these results is that the ancestral gnathostome MC2R likely had ligand binding sites with
an organization more similar to the wsMC2R: an open KKRRP binding pocket and an
HFRW binding pocket which is partially open. The partially accessible HFRW binding
pocket would allow for access to the MSH-sized ligands which lack the tetrabasic motif,
yet when stimulated with ACTH, the HFRW binding pocket becomes fully open, thus
explaining the greater sensitivity of wsMC2R to srACTH(1-24) than srDes-Acetyl-αMSH.
Then as species diverged, the esMC2R developed an even more accessible HFRW binding
pocket, while the bony vertebrates developed a closed HFRW binding pocket, explaining
their ligand selectivity for ACTH alone. Future studies which look more closely at the
specific ligand binding to these receptors may answer these remaining speculations
eventually.
Another phylogenetic implication which appeared as a result of the present study
concerns the interaction between the TM region of MRAP1 and its interaction with a TM
region of bony vertebrate MC2R orthologs. The characterization of wsMC2R determined
that the most likely region for this interaction between wsMC2R and wsMRAP1 is TM5
(Chapter 6). This differs from the determined region of interaction for hMC2R and
hMRAP1, which includes both TM4 and TM5 (Davis 2018). Additionally, the results of
this thesis demonstrated that it seems unlikely that the N-terminal of wsMRAP1 is
interacting with an extracellular region of wsMC2R (Chapter 5), while the hMRAP1 was
found to interact with hMC2R at EC2 (Davis 2018). Continuing with the notion that the
characteristics of wsMC2R most closely resemble ancestral condition of the gnathostome
MC2Rs, what this potentially suggests about the evolution of vertebrate MC2R orthologs
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is that the ancestral interaction between MC2R and MRAP1 was limited to TM5. Then, as
the bony vertebrates diverged and continued to evolve, a more dependent relationship on
MRAP1 led to the incorporation of TM4 and EC2 as additional regions of interaction. A
characterization of the region of interaction for the other MC2R orthologs of both
cartilaginous and bony vertebrates previously studied would allow for the development of
this trait throughout the phylogeny of vertebrates.

Implications of the wsMC2R Relationship with wsMRAP1 and wsMRAP2
Another interesting problem which the whale shark melanocortin system might
introduce is the case of the wsMRAP paralogs. In the initial characterization of the
wsMC2R it was seen that the wsMRAP2 paralog significantly increased trafficking of
wsMC2R to the cell surface (Figure 14E) which is incredibly unusual compared to the lack
of effect of MRAP2 on any other vertebrate MC2Rs previously studied. This suggests a
possibility that the annotated sequence for wsMRAP2 is not truly a unique wsMRAP2
paralog, but rather a duplication of wsMRAP1. The main difference between MRAP1 and
MRAP2 sequences is that the MRAP2 sequence lacks the activation motif (Sebag and
Hinkle 2009). However, the present thesis raises the question of whether the wsMRAP1
has this activation motif at all (Dores RM, personal communication) . While a motif similar
to the activation motif for other vertebrate MRAP1s is seen in the wsMRAP1 sequence,
the results of Chapters 2 and Chapter 5 question its importance or even presence.
Chimeric approach study of wsMC2R which replaced the extracellular regions with
corresponding sequences from other receptors revealed that it is unlikely that the N94

terminal of wsMRAP1 is interacting with an extracellular loop of wsMC2R to assist in
receptor activation. Taken with the observation of the activation and trafficking
improvement with ‘wsMRAP2,’ the activation motif may not be present at all. Future
studies which selectively mutated residues within the N-terminal of wsMRAP1 would be
able to reveal the accuracy to these suspicions.

Additional Future Directions
Overall, the results of this study provide valuable insight into the evolution of the
MC2R in vertebrates. The characteristics determined for the wsMC2R assist in developing
a thorough story of this receptor throughout the extant gnathostomes. From the foundation
of the present study, future research which looks into its many aspects in more depth will
surely enhance the body of research surrounding the MC2Rs of the cartilaginous fish and
bony vertebrates. One project is to continue the analysis of Chapter 4 and isolate individual
cysteine residues within EC3 of wsMC2R to determine the importance of each relatively.
Repeating a similarly structured experiment with the esMC2R and srMC2R as well will
also provide valuable insight into the evolution of the necessity of the key disulfide bridges
in the cartilaginous fish MC2R orthologs in general.
Further developments in modeling as well as various biochemical techniques
should be used to continue answering questions about the wsMC2R and the MC2R
orthologs of other species in order to fully improve the picture of the evolution of this
system. The phylogenetic relationships of the MC2R orthologs among cartilaginous fish
and bony vertebrates could be used as a model for understanding the evolutionary
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relationships of other similar conserved proteins, thus providing valuable outline for further
developments within the field of comparative endocrinology.
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CHAPTER 8: MATERIALS AND METHODS
Tissue Culture
All experiments were performed using Chinese Hamster Ovary (CHO) cells
(ATCC, Manassas, VA). Cells were grown in Kaighn’s Modification of Ham’s F12K
media (CORNING cellgroTM; Corning, NY). Media was supplemented with 10% fetal
bovine serum (CORNING cellgroTM; Corning, NY), 10 unit/ml penicillin, 100 μg/ml
streptomycin, and 100 μg/ml normacin (Complete CHO media). The cells were grown in
a 25 cm3 tissue vent-cap culture flask by CELLTREATTM (Pepperell, MA), and maintained
in a humid incubator with 95% air and 5% CO2 at 37oC. When the CHO cells reached 7080% confluence, cells were split into new culture flasks using 0.05% trypsin/0.53 mM
EDTA (CORNING cellgroTM; Corning, NY).

DNA Constructs
All wild-type MCR cDNAs were synthesized by GenScript (Piscataway, NJ) from
sequences available from GenBank [whale shark MC2R (Rhincodon typus; wsMC2R;
Accession #: XM_020525249.1), elephant shark MC2R (Callorhincus milii; esMC2R;
Accession #: FAA704.1), chicken MC2R (Gallus gallus; cMC2R; Accession #:
BAA24002.1), rainbow trout MC2R (Oncorhynchus mykiss; rtMC2R; Accession #:
ABV23494.1), frog (Xenopus tropicalis; xtMC1R; Accession #: XP_012817790), rainbow
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trout MC1R (Oncorhynchus mykiss; rtMC1R; CBL93118.1)] with an N-terminal V5
epitope tag and inserted into a pcDNA3.1+ vector. All chimeric and mutant receptors were
also synthesized by GenScript with an N-terminal V5 epitope tag and inserted into a
pcDNA3.1+ vector. Wild-type MRAP cDNA sequences were synthesized by GenScript
from sequences available from GenBank [whale shark MRAP1 (Rhincodon typus;
wsMRAP1; Accession #: XM_020520012.1), whale shark MRAP2 (Rhincodon typus;
wsMRAP2; Accession #: XM_020521799.1), elephant shark MRAP1 (Callorhincus milii;
esMRAP1; Accession #: XM_007903550), elephant shark MRAP2 (Callorhincus milii;
esMRAP2; Accession #: FAA00708.1)] with an N-terminal FLAG epitope tag and inserted
into a pcDNA3.1+ vectors. The cAMP reporter construct CRE-Luc (Chepurny and Holz
2007) was provided by Dr. Patricia Hinkle (University of Rochester, NY). All cDNA
constructs were separately inserted into individual pcDNA3.1+ vectors.

ACTH Peptides
Stingray ACTH(1-24), Human ACTH(1-24) and Stingray Des-Acetyl-α-MSH
were synthesized by New England Peptides (Boston, MA). Sequences for these peptides
can be found in Figures 5 and 15.

cAMP Reporter Assay (Luciferase Assay)
The MC2R ortholog cDNAs were transiently transfected into Chinese Hamster
Ovary (CHO) cells as described by Liang et. al (2011) and maintained at 37oC in an CO2
incubator. In order to observe the effects of the various ACTH analogs on functional
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receptor activation all transfections included the cAMP reporter construct CRE-Luciferase
(Chepurny and Holz, 2007). The transient transfections were done using a Solution T kit
(Lonza, Portsmouth, NH) and the Amaxa Cell Line Nucleofector II system (Lonza,
Portsmouth, NH). The transfected CHO cells were seeded in a white flat-bottom 96-well
plate (Corning Life Sciences, Manassas, VA) at a final density of 1x105 cells/well. After
a 48-hour incubation at 37oC, the cells were stimulated with analogs of hACTH(1-24)
(New England Peptide, Gardiner, MA) in serum-free CHO-media at concentrations
ranging from 10-12 M to 10-6 M. The analogs of hACTH(1-24) used for this study are
presented in Table 1.
Following a 4-hour incubation at 37oC, the stimulating solutions were removed and
a luciferase substrate reagent (BrightGLO; Promega, WI) was added to each well as
described in Liang et. al (2011). Cells incubated with standard hACTH(1-24) were
included with each experimental group as a control. A Bio-TEK Synergy HTX plate reader
(Winooski, VT) measured the luminescence generated after a five-minute incubation
period at room temperature. Transfected CHO cells incubated with serum-free media, but
no ACTH, were analyzed along with each experimental group to determine basal cAMP
levels.
Luminescence readings were corrected by subtracting the basal cAMP readings
(serum-free media/no ligand) for each transfection dose response curve. The data for each
dose response curve were fitted to the Michaelis-Menten equation to obtain EC50 values
using Kaleidograph software (www.synergy.com). Data points are expressed as the mean
± SEM (n=3). To analyze the level of activation between different ACTH analogs, the
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corrected data sets were analyzed using either a student’s paired T-test or One-Way
ANOVA followed by Tukey’s multi-comparison test using GraphPad Prism 2 software
(GraphPad Inc, La Jolla, CA, USA). Significance was set at p < 0.05.

Cell Surface ELISA
CHO cells were plated at 0.75 x 105 cells/well in a fibronectin-treated 24-well
culture dish and grown overnight in in a 37oC CO2 incubator. Cells were transfected with
select cDNA plasmids using jetPRIME transfection reagents (Polyplus transfection,
Illkirch, France). After 48-hours, cells were fixed in 4% Paraformaldehyde, washed and
then incubated with mouse monoclonal V5-epitope antibody (Abcam; #ab27671) followed
by secondary HRP-conjugated goat anti-mouse antibody (ROCKLAND Antibodies; #6101319-1000).

Cells

were

washed

and

treated

with

one-step

2,2’azinobis-

3ethylbenzthiazoline-6-sulfonic acid (one-step ABTS) (Thermo Fisher Scientific,
Waltham, MA, USA). Aliquots of supernatant were transferred to a 96-well plate and
absorbance at 405 nm was determined using a Bio-TEK Synergy HTX plate reader (Agilent
Technologies, Santa Clara, CA, USA). Data was analyzed using a one-way ANOVA with
Tukey’s multi-comparison post-test using GraphPad Prism software (GraphPad Inc, La
Jolla, CA, USA). Significance was set at p <0.05.

Cell Surface Immunofluorescent Confocal Microscopy
CHO cells were plated on fibronectin-treated 35mm glass-bottomed imaging dishes
at a density of 3.5 x 104 cells/dish and grown overnight in a 37oC CO2 incubator. After 24
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hours, cells were transfected using FuGENE transfection reagent (FuGENE HD; Promega,
WI) at a ratio of 3:1 (FuGENE: cDNA). A no plasmid control with no cDNA was included
as a control (see Supplementary Figure 1 below).
24 hours post-transfection, media was removed, and cells were fixed using Bouin’s
solution (5% acetic acid, 9% formaldehyde, 0.9% picric acid) then rinsed with 1x PBS. For
each cDNA included, a plate was permeabilized as a control using 0.1% trypsin in PBS for
15min. Cells were then blocked using a block solution of 2% BSA and 5% Normal Goat
Serum in 1x PBS. Primary antibody (mouse monoclonal [SV5-Pk1] to V5 tag; Abcam,
#ab27671) in block solution (1:1000) was then applied for 90-min, then rinsed with 1x
PBS. For each cDNA included, a secondary-only plate was included as a control, which
incubated with only block solution during this period.
Secondary antibody [IgG (H+L) Goat anti-Mouse, Alexa Fluor 488 (Invitrogen
#A11006), IgG (H+L) Goat anti-Mouse, Alexa Fluor 568 (Invitrogen #A11004), or IgG
(H+L) Goat anti-Mouse, Alexa Fluor 647 ( Invitrogen #A21235)] in block solution (1:200)
was then applied for 60-min, then rinsed with 1x PBS. Cells were kept in a light-blocking
box as much as possible after application of the secondary antibody. After rinsing,
mounting solution with DAPI (Invitrogen #00495952) and a glass coverslip was applied to
the cells. Edges were sealed with clear nail polish.
Imaging was done using an Olympus Fluoview FV3000 Confocal Laser Scanning
microscope with a UPLanSApo 100x/1.40 Oil Infinity/0.17FN26.5 UIS2 microscope
objective. Wavelength of lasers used for images were 405nm, 488nm, 561nm, 640nm.
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Supplementary Figure 1. Immunofluorescent cell-surface imaging noplasmid controls. Images of non-permeabilized cells. Images show
maximum z projections. Scale bar = 1μm. A) No plasmid control for
Figure 21 (wsMC2R/xtMC1R EC2 chimeric), Figure 22
(wsMC2R/esMC3R EC2 chimeric) and Figure 25 (wsMC2R/xtMC1R
TM4-EC2-TM5 chimerics), B) No plasmid control for Figure 20
(wsMC2R/xtMCC1R NT & EC3 cysteine chimerics), C) No plasmid
control for Figure 28 (SFFF single-alanine mutants), D) No plasmid
control for Figure 23 (xtMC1R EC1 Chimeric), E) No plasmid control
for Figure 29 (VLFF single-alanine mutants).
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Software for image rendering was Olympus Fluoview (Olympus FV31S-SW Version
2.4.1.198; copyright OLYMPUS CORPORATION).
Images were analyzed for mean fluorescence using Fuji imaging software
(Schindelin et al. 2012). Data was analyzed using a one-way ANOVA with Tukey’s multicomparison post-test using GraphPad Prism software (GraphPad Inc, La Jolla, CA, USA).
Significance was set at p < 0.05.

Statistical Analysis
All data points are represented as a mean ± standard error values obtained from
experiments performed in a triplicate. Statistical significance was determined utilizing an
unpaired two-tailed student’s t-test for equal variance for Figures 14A, 14B, 14C, 14D, 15,
19A, 19B, 19C, 19D, 21B, 21C, 22B, 22C (significance was set at p ≤ 0.05) or by using a
one-way ANOVA, followed by either Tukey’s or Dunnett’s multi-comparison test to
compare three or more dose response curves for Figures 14E, 16A, 16B, 16C, 16D, 20B,
21E, 22E, 24B, 24C, 24E, 24F, 25B, 26A, 26B, 26C, 26D, 27, 28, 29 (Significance set at
p ≤ 0.05). Statistical analyses calculated using the GraphPad Prism 2 software (GraphPad
Software Inc., La Jolla, CA, USA). Significance was set at p ≤ 0.05.
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